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Diplomityön tarkoitus oli koota tietoa magnesiumista sekä materiaalina että sen
käytöstä lääketieteellisiin tarkoituksiin ja tarkastella magnesium metallin
ominaisuuksia.  Käytännön työnä oli tarkoitus testata Mg-10Gd-1Nd-1Zn lejeeringin
hajoavuutta poly(l-laktidi-co-dl-laktidi) (PLDLA) 50:50 polymeerikomposiitissa.
Tavoitteena oli arvioida käytettyjen metallien asemaa lääketieteellisistä välineistä
implanttituotteisiin asti ja tutkia, että onko biohajoavia metalleja käytössä näissä
sovelluksissa. Kirjallisuustutkimuksen tarkoituksena oli selvittää voiko magnesiumia
käyttää lääketieteellisesti ja kokeellisessa osiossa selvittää sen hajoamisprofiilia.
Magnesium on tunnettu materiaali, jonka ominaisuudet ovat tehneet siitä tärkeän
monessa eri käyttökohteessa jossa materiaalin keveys on tärkeä ominaisuus.
Magnesiummetallin bioyhteensopivuus on kiinnittänyt tutkijoiden huomiota. Nopea
hajoaminen on kuitenkin aiheuttanut ongelmia implanttisovelluksissa. Viime aikoina
huomio magnesiumia kohtaan on kasvanut luuimplanttien, stenttien sekä implanttien,
jotka hyödyntävät sähköä toiminnassaan kuten ihon alle sijoitettavat anturit,
suunnittelussa. Materiaalia on jo tutkittu prekliinisesti eräiden implanttisovellusten
kohdalla. Nämä tutkimukset ovat olleet lupaavia, mutta ristiriitaiset tulokset tutkimusten
välillä sekä metallin tai sen lejeerinkien turvallisuus kliinisessä käytössä ovat
toistaiseksi estäneet tuotteiden laajemman kaupallisen käytön. Tutkimustulosten
pohjalta on esitetty, että kehon sisäisenä implantti materiaalina magnesium on
turvallista käyttää kun hajoamisnopeus on alle 0.01 ml/cm2/päivä.
Käytännön työssä Mg-lejeerinkiä käytettiin sinänsä sekä siitä valmistettiin
komposiitteja joissa oli 67–92 wt-% PLDLA 50:50 polymeeriä. Työ keskittyi pH-
mittauksiin sekä visuaaliseen tarkasteluun mikroskoopilla. Tulokset osoittivat, että
lejeerinki materiaali hajoaa tehokkaammin "Sørensen" puskuriliuoksessa kuin de-
ionisoidussa vedessä. Lejeerinki saa fosfaatti-kerroksen päälleen jo muutaman päivän
aikana puskuriliuoksessa. Polymeeri hidasti magnesium lejeeringin hajoavuustahtia
verrattuna magnesium lejeerinki näytteisiin nähden. Implanttisovelluksia varten
komposiittimateriaali vaatii lisää tutkimusta, jotta sen käyttöä ja soveltuvuutta voidaan
määrittää tarkemmin.
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The goal of the work was to review known metallic materials and especially magnesium
that are used for medical purposes. The intention was to review the role of the current
metallic materials, covering the field from medical utensils to actual implant products
and to find if there are any degradable metals used. Other purpose was to determine if
magnesium is suitable for medical applications with a focus on the alloy's degradation
properties in the practical section. Here the Mg-10Gd-1Nd-1Zn alloy's degradation
behavior was studied when it was used in composite structure with poly(l-lactide-co-dl-
lactide) (PLDLA) 50:50.
Magnesium metal is well-known and commonly used material. Its influence in
different fields has made it an important material with applications that are used due to
the light weight of the material when compared to other metal materials. Magnesium’s
biocompatibility has made the material gain attention in the medical field. On the other
hand, due to magnesium’s fast degradation rate, it has been difficult to use the material
for medical applications. Recently, though, magnesium has been studied and planned to
be used for medical implants for bone and electrical applications. The material has been
used for certain implant application already but only in pre-clinical testings. These tests
have shown that the material is almost suitable as it is for some applications but
conflicting results from different sources and safety aspects have prevented its use.
Studies propose that, for safe in vivo use, a suitable degradation rate should be under
0.01 ml/cm2/day.
Testing the Mg-10Gd-1Nd-1Zn alloy by itself and as a composite with 67-92 wt-%
PLDLA 50:50 polymer resulted in various results. Work was focused on pH-
measurements and microscope imaging. Results indicated that the alloy degraded more
rapidly in a "Sørensen" buffer solution than in di-ionized water immersion. The alloy
also gained a phosphate layer on top of the metal in a few days in the buffer solution. It
was also noticed that the polymer was able to hinder degradation of the magnesium
material heavily. In that respect the magnesium alloy in a composite might be promising
for implant applications for its electrical properties but further research is needed to
determine this.
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11 INTRODUCTION
Metal materials have an important role in the medical field. Choosing the right material
can mean the success over a failure situation which is why metals have been used
extensively even if they are not perfect for the purpose. One interesting metal is
magnesium, which has low density when compared to other metals. It has been known
for over two centuries now and has been widely used for several different applications
by, different industrial fields but it has not been widely used in the medical field.
Medical field, especially, thrives on innovation which is why new material solutions
emerge constantly to solve existing problems. Magnesium is now gaining even more
interest due to the improved technological capabilities and knowledge about the
material.
A common property with metals is that most of them have one of the three different
primary crystal structures. These three types, presented in Figure 1, are face centered
cubic (FCC), hexagonal close-packed (HCP) and body-centered cubic (BCC). Some
metals can have, though, other crystal structures like double hexagonal, monoclinic,
orthorhombic, rhombohedral, tetragonal and trigonal crystal structures to name a few
more.
Figure 1. Unit cells of metal crystal structures: face centered cubic (FCC), hexagonal
close-packed (HCP) and body-centered cubic (BCC).
Metal materials used in the medical field usually provide some kind of advantage
over the other materials. These advantages are usually, strength, toughness, biostability
and easy to make sterile. Due to these properties, metals are mainly used as utensils and
other medical instruments. In some cases they are used as implants like hip prostheses
and heart pacers. Biodegradable applications, though, usually fall outside the metal
material group until recently. Iron and magnesium, being the exceptions in the metal
materials, are biodegradable. This has led to multiple studies about them.
Magnesium's history shows that the material contains a lot of potential, which is not
yet fully obtained. Magnesium has especially been studied due to its biocompatibility.
Medical studies concentrating on magnesium have been around for over 100 years now.
2These have ranged from in vitro to small animal studies and human studies. In some
cases the results have been promising and in others not. Due to conflicting results,
magnesium as a metal has not been commercialized in the medical field for implant
applications. The promising results, though, have kept the interest in the material and its
research.
Our research in this paper now focuses on magnesium and its possibilities as a
biomedical material. The practical work is concentrated to study a magnesium alloy, its
degradation properties and how it reacts under aqueous surrounding when embedded
into a biodegradable polymer. What further is determined are the materials possibilities
as an implant material in electrically conductive composites.
32 BIOSTABILE METALS AND ALLOYS IN
BIOMEDICINE
In the field of materials science, there are a large number of metal materials and alloys.
There are frequently new and unique material combinations used to solve technical
problems.  In  this  chapter,  the  focus  is  on  metals  that  have  been  used  to  solve  the
technical problems in the medical field in ways that are known. The most common and
some not so common metals and the applications they are used in are discussed to
understand their role in the medical field.
When metals in biomedicine are discussed, stainless steels are the group of metals
that  stand  out.  This  group  consists  of  multiple  different  versions  of  the  same  larger
group. Other metals are also in an important role in biomedicine. These materials are
metals based on cobalt, titanium, nickel, tantalum, zirconium, tungsten and silver.
2.1 Stainless steels
Stainless steels are considered as one of the most important group of metal materials in
biomedicine for the last few decades. This material group has kept its importance in the
medical field because it is easy to manufacture and process for products. Stainless steels
have different crystalline structures that include martensitic, ferritic, austenitic and
duplex. Each of these structures has a different effect on the material's properties.
Stainless steels also have good corrosion resistance in oxygen based environment,
which is due to chromium and nickel, or molybdenum and nitrogen additions. [14; 53;
57.] This resistance comes from a protective oxide layer that these additions create. This
layer works against pitting corrosion which is a very common type of corrosion in metal
materials. These additions also improve the mechanical strength of these metals. [66.]
2.1.1 Martensitic
Martensitic stainless steels are alloys that consist of a Fe-Cr-C combination, where the
chromium content is around 10.5 to 18 % and the carbon content is around 1.2 %. This
material has a body-centered tetragonal crystal structure which is defined as a
martensitic structure. The material is generally ferromagnetic in nature and can be
hardened through heat treatment. As stated earlier, stainless steels have good corrosion
resistance. With martensitic materials, this resistance is good in low moisture
conditions. The addition of some specific chemical element into the martensitic
stainless steels can alter certain properties of the metal. Adding niobium, silicon,
tungsten or vanadium results to changes in tempering procedure that happens after the
hardening process. If we want to improve the mechanical strength and toughness or
corrosion resistance, then we can add nickel to the alloy. If we want to improve
4machinability  of  the  alloy,  then  we  need  to  add  small  amounts  of  sulfur  or  selenium.
[14; 57.]
Martensitic stainless steel is used in applications where high hardness is needed, like
dental and surgical instruments. These include dental chisels, scalpels, bone chisels,
bone gouges, and orthodontic pliers to name a few. Because of the limitations of the
martensitic structure, other forms of stainless steels have been used for more corroding
conditions. [14.]
2.1.2 Ferritic
With ferritic stainless steels materials, the structure combination is Fe-Cr. This alloy has
a body-centered cubic (BCC) crystal structure. In contrast to martensitic materials, the
ferritic alloy has 11 to 30 % of chromium. As with martensitic alloys, certain materials
can be used to improve specific characteristics of ferritic stainless steels. Some of these
materials are molybdenum, silicon, aluminum, titanium, niobium, sulfur and selenium.
Materials like sulfur and selenium can for example improve the machinability of the
alloy while molybdenum can improve toughness. [14; 57.]
Ferritic materials cannot be strengthened through heat treatment, additionally, they
can strain-harden relatively slowly and with cold working, the materials ductility is
greatly lowered. Because of these limitations, ferritic materials are not really used in
medical applications. The material has been in use only in solid handles, guide pins and
fasteners. [14.]
2.1.3 Austenitic
Austenitic stainless steels (ASS) is the most used stainless steel group in the medical
field. The chronium content of austenitic steels is around 16 to 26 %, nickel content is
35 % or less and manganese content is 15% or less. These ratios are different compared
to other stainless steels. Austenitic steels resemble ferritic steels since they cannot be
hardened through heat treatment, although, austenitic steels are not magnetic in their
annealed state compared to ferritic steels. Austenitic steels can only be hardened
through cold working. Austenitic steels are good at cryogenic conditions and have good
to high temperature strength and oxidation resistance. [14; 57.]
Austenitic steels can be modified by adding different metals like molybdenum,
copper, silicon, aluminum, titanium or niobium to improve halide pitting resistance,
oxidation resistance and formability. By altering nickel content you can adjust the
response to deformation and gain better formability. [14.] Austenitic stainless steels are
used where good corrosion resistance and moderate strength are the key factors. These
applications include dental impression trays, hypodermic needles, work surfaces and
steam sterilizer equipment. [14; 53.]
52.1.4 Duplex
Duplex alloys are two phase alloys based on Fe-Cr-Ni systems. This alloy is comprised
of equal amounts of austenitic and ferritic phases in the alloys microstructure. The
carbon content of this material is very low, under 0.03 %. The alloy can contain small
amounts of molybdenum, nitrogen, tungsten and copper. The chromium content is from
20 to 30 % and nickel content is from 5 to 8 %. Small differences in the metal amounts
and the different phases in the microstructure have led to specific properties. The duplex
alloys have better tensile strength than austenitic stainless steels. Toughness and
ductility values are improved when compared to ferritic grades. This alloy group also
has superior chloride stress corrosion cracking resistance and pitting corrosion
resistance. This alloy has not been used much in the medical field but they might prove
to be important in the future. [14; 57.]
2.1.5 Precipitation-hardenable
Another not so common group is precipitation-hardenable stainless steels (PH stainless
steels). In this group, chromium and nickel are the dominant materials. Hardening, of
this  alloy  type,  is  done  by  aging  treatment.  With  this  method,  austenitic  to  semi-
austenitic or martensitic structures can be obtained. The classification of this group is
due to their solution-annealed microstructure. [14.]
Semi-austenitic structures can be heat-treated to gain a martensitic structure.
Utilizing cold working can speed up the aging process. The aging process itself can also
be improved by adding aluminum, titanium, niobium or copper. In the field of medical
applications, both semi-austenitic and martensitic precipitation-hardened steels are used.
Applications range from neurosurgical aneurysm and micro-vascular clips to surgical
and dental instruments. On the other hand, austenitic grades of precipitation-hardened
steels are not used in the medical field. [14; 57.]
2.1.6 Implant grade
Most of the stainless steels are used for transient contact to the human skin and tissue.
This has resulted to a additional classification of implant grade stainless steels that are
suitable  to  be  used  in  contact  with  the  human tissue.  This  group consists  of  austenitic
stainless steels (ASS). They are inexpensive as their manufacturing and processing is
done through common techniques. Their mechanical properties can be adjusted to gain
optimal strength and ductility for the alloy. The classification of these steels is wrought
alloys since they are forged and machined. These alloys can additionally gain passivity
by immersing them on nitric acid to create a protective layer, before they are sterilized
and packaged. The corrosion behavior of the materials prevents long term implant use.
Even with this critical limitation, they are being used as bone screws, plates, nails, rods
and other temporary fixation devices that are removed after a desired time period
postoperatively. [14.]
6Implant grade stainless steels contain a additional group, which is low carbon
stainless steels, typically named as type 316L which is comprised of under 0.08 %
carbon, 18% of chromium, 14 % of nickel and about 2.5 % of molybdenum. These
metals are vacuum melted to gain the low carbon variation from type 316 alloys.
Utilizing vacuum melting also improves cleanliness of the process. Pitting corrosion
resistance can be maximized with a ferrite free microstructure. Grain size should be
uniform throughout the specimen so that any specifically wanted property can be
obtained. [14; 53; 57.]
This group is generally used in the 30% cold worked state as this increases the yield
and ultimate tensile strength and fatigue strengths of the material when compared to
annealed metals. These properties result to the material's lower ductility. This group can
be welded but this can sensitize the material which is not wanted. [14.] The 316L steels
can be used as wires for temporary solutions. Vacuum melted 316L are used in
temporary fixation applications like plates, screws, wires, sutures and clips for example.
Additionally, the type 316L material is most common in total joint prostheses. [14; 53.]
2.1.7 Nitrogen-strengthened
Nitrogen-strengthened metal group is gained by utilizing nitrogen to increase the metals
properties. These strengthened metals have increased corrosion resistance (both crevice
and pitting). The mechanical properties like tensile strength, impact strength and fatigue
strength are better when compared to 316L stainless steels. The improvement is gained
by using the electro slag refining (ESR) process. Improvement over 316L steels has
resulted these types of stainless steels to be used for bone plates, bone screws, spinal
fixation components and other medical applications that require higher mechanical and
corrosion resistance properties. Nitrogen-strengthened stainless steels have been utilized
especially with fracture fixation as the material can gain high ultimate tensile strengths,
nearing 1380 MPa. [14.]
2.2 Cobalt alloys
Cobalt-based metal alloys came into use in the 1930s. Cobalt metals have high
mechanical properties when compared to other metals due to the existence of solid-
solution elements and carbides in the alloy. The corrosion resistance is lower than with
stainless steels even though their resistance ability comes from chromium as in stainless
steels. Cobalt-based alloys still have had an important part in the development of
medical materials even if wrought metals have started to replace them. [14.]
Cobalt-based materials have been divided into four main alloy groups and into three
special groups in the medical field, seen in Table 1. Some of the composition ratios can
differ from the mentioned in the table. For example, with ASTM F 75 the composition
can alter from 27 to 30 wt-% Chromium and from 5 to 7 wt-% with Molybdenum. [14.]
7Table 1. Alloy groups of cobalt in medical applications. [14.]
Alloy Composition Use
ASTM F 75 Co-28Cr-6Mo Casting alloy
ASTM F 90 Co-20Cr-15W-10Ni Wrought alloy
ASTM F 799 Co-28Cr-6Mo Similar  to  ASTM  F  75,  but
thermomechanically processed.
ASTM F 562 Co-35Ni-20Cr-10Mo Wrought alloy
ASTM F 563 Co-Ni-Cr-Mo-Fe Wrought alloy
ASTM F 1058 Co-Cr-Ni-Mo-Fe Wrought alloy
UNS R30004 Co-Cr-Ni-W-Mo Cast or Wrought alloy
The strength of cobalt-based wrought alloys can be enhanced through cold working
just like austenitic alloys. Wrought alloys have about 0.05 % carbon when compared to
casting alloys 0.25 % carbon. Difference between carbon amounts means that wrought
alloys have less strength coming from carbides. Fabricability can be enhanced with
cobalt-based alloys by decreasing the chromium content and increasing the nickel
amount. [14; 57.]
Wrought  alloys  have  the  ability  to  be  hot  worked  and  some  of  them  can  be  cold
drawn. Yield strength is highly influenced by grain size and the degree of cold work
done  to  the  material.  Forging  of  metal  alloys  for  medical  purposes  will  restrict  the
material  to  be  used  for  structural  applications  and  should  be  done  only  when  optimal
properties for tensile strength and toughness are desired. Forging can result to non-
uniform grain sizes to the material which is not desired. [14; 53; 57.]
Cobalt-based alloys are more difficult to machine than stainless steel alloys. Closed-
die forging can be utilized to make the process easier but wrought alloys required more
machining than casting alloys. Investment casting can be used to create implants at
lower cost range if the compression and tensile strength of the material is not an
important factor. Investment casting causes the material to have larger grain sizes, lower
strength, lower cost and possible problems with porosity. Porosity and grain sizes,
though, can be adjusted by improving the casting molds and by utilizing hot isostatic
pressing (HIP) in post-cast treatment of vacuum investment-cast alloys. HIP can be used
with powder metallurgy to gain fine grains and very good properties but with higher
cost. With HIP cobalt-chromium alloys can be used for applications like hip prostheses
to some extent. These positive and negative aspects result to the fact that cost and
properties are against each other in choosing the preferred method for the creation of
any possible and wanted implant application. [14; 57.]
ASTM F 75 alloys are commercially named as Vitallium or Haynes 21. The alloy
has good corrosion resistance in chloride environments due to the high chromium
content seen in table 1. Another reason is the formation of a protective oxide layer
consisting of Cr2O3. Casted cobalt implant alloys generally have large and coarse grain
sizes due to large mold sizes during manufacturing, which results to poorer mechanical
properties compared to methods that provide fine grain sizes. Structure of ASTM F 75
8alloys consists of carbides in grain boundaries and grains that contain cobalt, chromium
or molybdenum and carbon in the following way X23C6.  The alloy can also consist  of
sigma and gamma phases based on cobalt, cobalt-base and molybdenum. [14; 57.]
ASTM F 90 alloys are commercially named as Haynes 25 and L-605. ASTM F 90
alloys have improved machinability and fabrication properties when compared to
ASTM F 75 alloys, due to additions of tungsten and nickel. In the annealed state ASTM
F 90 is similar to ASTM F 75 group. Differences between these groups arise when the
F90 material is cold worked to 44 % which results to over doubling the machinability
and fabrication properties. [14; 57.]
ASTM F 799 group is modified from the ASTM F 75 group through mechanical
processing. This is done by hot forging rough billets in to the wanted shapes. ASTM F
799 has a more worked grain structure and a hexagonal close-packed phase (HCP),
which is formed through shear-induced transformation of face-centered cubic (FCC)
matrix. ASTM F 799 group has about twice the fatigue, yield and ultimate tensile
strength when compared to ASTM F 75 alloys. Good mechanical properties can also be
gained through the use of powder metallurgy with HIP due to finer microstructure of the
alloy. Wear properties are also enhanced through HIP, which has been used in contact
with ultra-high molecular weight polyethene (UHMWPE) or ASTM F 799 alloy cups in
joint implants. [14; 57.]
ASTM F 562 alloys  are  commercially  sometimes  named as  MP35N.  These  alloys
have high strength, ductility, corrosion resistance and stress-corrosion cracking
resistance compared to other cobalt-based alloys. Higher strength of the alloy is gained
from the phase transformation of the material which changes from FCC crystal structure
to a HCP crystal structure through the use of cold working due to high cobalt content.
Different crystal structures in the alloy make the material harder as the structures
prevent dislocation movement through the crystal structure barriers. Tensile strength
can be increased with cold-working and aging to over 1795 MPa. This tensile strength is
higher than the current highest surgical implant. [14.] The alloy can experience over 8
% of elongations, which can create unwanted problems if [57].
ASTM F 563, ASTM F 1058 and UNS R30004 have been standardized for the use
of medical devices and have no harmful effects in terms of cytotoxicity, systemic
toxicity, intracutaneous irritation, intramuscular implantation, skin sensitization, blood
hemolysis or pyrogenicity. ASTM F 563 has been used in bars, wires and forgings.
ASTM F 1058 has higher chromium content than nickel. ASTM F 1058 has been used
in heart springs and in neurosurgery and vascular surgery if the material has been aged.
These two metals can be strengthened through cold working and aging. UNS R30004,
also known as Havar, has been in consideration for medical implants but has not been
used in applications yet. [14; 57.]
92.3 Titanium and titanium alloys
Titanium is a commonly used material in the medical field due to its use in joint
implants because of its biocompatibility. The densities of titanium alloys are low when
compared for example to stainless steels, around 50 to 60 % of 316L stainless steels
density. Titanium can be strengthened by alloying and deformation processing.
Corrosion behavior for the material is low due to a protective oxide layer. This oxide
layer can reform itself if it is damaged even under low loads and slow sliding speeds in
articulating conditions. If the protective film is removed and does not generate back, the
material will experience galling that causes metal-to-metal contact and cold welding for
example in joint implant situations. This then will result in high friction and wear rates.
Titanium's wear can prevented with methods like: coating with vapor deposition of
titanium-nickel (TiN) or titanium-carbon (TiC), ion implantation of N+, thermal
treatments like nitriding and oxygen diffusion hardening, and laser alloying with TiC.
Titanium also has a low modulus when compared to stainless-steel and cobalt based
alloys.  Due  to  these  properties,  pure  titanium  (CP-Ti),  α +  β (Ti-6Al-4V)  alloys  and
recently new compositions and orthopedic metastable β alloys have been used more in
the medical field. [14; 57.]
Titanium has different crystal structures depending on the temperature used during
the manufacturing. The α-phase of titanium causes HCP crystal structure and β-phase
causes BCC crystal structure for the material. Temperature limit in which this change
happens (allotropic transformation) is highly influenced by the interstitial elements of α-
and β-stabilizers. The α- and β-phases divide the material into four different types which
are α-, near-α, α-β and β-alloys. [14; 53; 57.]
Materials like tantalum, vanadium, molybdenum and niobium are β-isomorphous,
with similar phase relations, with BCC titanium. Titanium does not form intermetallic
compounds  with  these  kinds  of  materials.  For  α-β alloys  the  elements  are  distributed
equally between the two phases. Commercial titanium alloys typically contains one or
more elements as they generally improve creep strength in the α-phase. Additions like
iron and chronium can be used in β-rich, α-β or in β-alloys to improve hardenability and
response to heat-treatment as they are β-stabilizers. Improving corrosion resistance of
non-alloyed titanium can be done by adding nickel, molybdenum, palladium or
ruthenium. [14; 57.]
Commercial titanium grades for medical purposes are divided to three groups which
are  unalloyed  commercially  pure  (CP-Ti)  grades,  α-β alloys  and  β-alloys.  α-β alloy
group contains the Ti-6Al-4V alloy that is used in hip prostheses and which is used
when evaluating fatigue resistance of orthopedic titanium alloys. Ti-6Al-4V alloy has
about 45 % section of titanium production. Unalloyed titanium holds about 30 %
section and the rest hold the 25 % amount. [14; 53; 57.]
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2.3.1 Commercially pure titanium
Commercially pure titanium consists of 98.9 % to 99.6 % pure titanium and has the α-
phase with the HCP crystal structure. The material has low strength and high ductility
but  good  corrosion  resistance  due  to  low  amount  of  impurities  in  the  structure.  Yield
strength of the material can range from 170 to 480 MPa, depending on the impurity
amount. Increasing the oxygen and iron content in the material increases the strength
and fatigue strength of the material. High solubility of elements like oxygen and
nitrogen causes titanium to have oxidation and solid-solution hardening on surface. This
is caused by the inward diffusion of these elements. The surface-hardened layer can be
removed by machining, chemical milling or other mechanical ways if needed. This layer
is sometimes removed as it has a α-phase which reduces fatigue strength and ductility.
[14; 57.]
Commercially pure titanium is used in applications like pacemaker cases, housings
for ventricular-assist devices and implantable infusion drug pumps. Other applications
include dental implants, maxillofacial implants, craniomaxillofacial implants, screws
and stables for spinal surgery. [14; 53; 57.]
2.3.2 Alpha-beta alloys
The α-β alloys consist of α- and β-phases in which the β-phase is present due to retained
structure or transformed structure of the alloy. Solution-treating and aging can increase
the  α-β alloys  tensile  strength  from  30  to  50  %  over  the  annealed  or  over-aged
conditions. Alpha-beta alloys have high notch sensitivity as they can lose to 40% of
their rotating bending fatigue strength. The fatigue limit is reduced with notched
surfaces and porous samples. [14; 57.]
At this time, there are at least four different α-β alloys that have been standardized
by the ASTM. Ti-6Al-4V and Ti-6Al-4V ELI are the most commonly used out of the
four alloys due to their use in total joint replacement arthroplasty. Ti-6Al-7Nb has been
used for femoral hip stems, fracture fixation plates, spinal components, fasteners, nails,
rods, screws and wire. Ti-3Al-2.5V has been used for tubing and intramedullary nails
because it has 20 to 50 % higher tensile properties than CP-Ti. [14.]
2.3.3 Beta alloys
The β-alloys retain their β-phase on cooling to room temperatures but can precipitate
secondary phases when heat-treated. Beta alloys have higher hardenability properties
than α-alloys. Beta alloys also have excellent forgeability, cold-rolling capabilities and
in sheet form they can be cold brake-formed more readily than the other titanium alloys.
Beta alloys cannot be work hardened much as they experience necking in complex
forming  operations.  Solution  treating  and  aging  can  be  used  to  improve  the  tensile
strength, ductility, toughness and formability of the alloy when compared to aged α-β
alloys. The density of β-alloys is higher than α-β alloys and they have lower creep
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strength and lower tensile ductility when aged. Fracture toughness of an aged beta alloy
is higher than that of an α-β alloy with similar yield strength. [14; 57.]
Beta alloys are not suited for elevated-temperature applications or services unless
they are stabilized or overaged treated before use. Beta alloys are used in applications
that require lower elastic moduli and enhanced biocompatibility when compared to α-β
alloys. Beta alloys have been used also in joint applications due to their properties. [14;
53; 57.]
2.4 Nickel-titanium
Nickel-titanium (NiTi) alloys are used as shape memory alloys (SMA) for biomedical
devices. Shape memory alloys have the ability to return to some previously determined
shape or size when the material is subjected to a certain thermal procedure. This
deformation happens plastically. When the shape memory effect is only caused by
heating the material is a one-way shape memory material. Two-way shape memory
materials have the reverse effect when cooled. These materials can recover from a state
that has a substantial amount of strain. The shape memory reaction with nickel-titanium
alloys react through martensitic transformation which allows the alloys to be deformed
by a twinning mechanism below the transformation temperature. The transformation of
the martensitic structure yields a thermoelastic martensite that develops from a high-
temperature austenitic phase with a long-range order. The shape memory transformation
process happens in a narrow temperature range and has s hysteresis loop to it which
means that the cooling and heating process transformation happens at different
temperatures. [14; 57.]
For nickel-titanium systems the alloy is binary equiatomic with about 49 to 51 % Ni
in the alloy. NiTi alloys have a moderate solubility range for excess nickel or titanium,
as well as other metallic elements. The alloys ductility is very comparable to other metal
alloys. Alloying with iron and chromium can lead to lower transformation temperature.
With copper the alloy has decreased hysteresis loop and lower deformation stress of the
martensite structure. Oxygen and carbon shift the transformation temperature and lower
the mechanical properties of the alloy which is why these elements should be minimized
or avoided completely. [14; 57.]
Work hardening and heat-treatment improve the ease of the deformation of the
martensite structure. These processes also provide much greater tensile strength to the
austenite structure and the property to move itself spontaneously on heating and on
cooling. [14; 57.]
Processing is done in a vacuum or an inert atmosphere due to the reactivity of the
oxide surface to the titanium material. Plasma arc melting, electron beam melting and
vacuum induction melting are commonly used with NiTi alloys. The alloy can be hot-
formed with methods like forging, bar rolling and extrusion. Cold-working can be used
but requires frequent annealing due to fast work hardening. The most common method
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for NiTi alloys is wire drawing as it provides excellent surface properties and the sizes
of the wire can be made as small as 0.05 mm. [14.]
NiTi alloys can be used as osteosynthesis plates where the plate contracts and pulls
the fractured surfaces together. Applications also include medical staples for broken
bones, blood-clot filters to anchor themselves to the vein walls and catch passing clots.
Other applications for SMAs are orthodontic wires and endodontic instruments.
Potential applications that are not yet used are for example hip prostheses, anterior
cruciate ligament prostheses and endoprostheses. [14; 53; 57.]
2.5 Tantalum
Tantalum belongs to a group named refractory metals. These metals like niobium,
molybdenum and tungsten are mostly used as alloying elements in the medical field.
They have the highest melting temperatures, usually above 2000 oC, and lowest vapor
pressures of all metals. Tantalum differs from the rest in that commercially pure and
unalloyed tantalum that is at least 99.90 % pure is used for a variety of different medical
devices. Tantalum has excellent corrosion resistance against a large number of acids,
aqueous solutions of salts, organic chemicals, and various combinations and mixtures of
these agents. The high corrosion resistance of the metal can be compared to the level of
glass. Tantalum additionally has a good biocompatibility. [14; 57.]
Tantalum is used for example in general surgery and neurosurgery as a
monofilament suture. It is also used as a braided suture wire for skin closure and tendon
repair. It is also used as foils and sheets for nerve anastomoses. Tantalum is additionally
used as clips for the ligation of vessels, staples for abdominal surgery and as pliable
sheets and plates for cranioplasty and reconstructive surgery. The metal in sintered state
is also used as capacitor electrodes in electrical stimulation devices. It can be utilized as
coatings for carbon foam skeletons that are used as biocompatible replacements for
vertebral  bodies  in  the  spinal  column.  The  coating  is  around  70  to  80  %  porous  and
resembles the appearance of cancellous bone. Tantalum is also currently being
considered as an alloy with carbon for hip and knee construction and a bone scaffold for
void-filling products and applications. [14; 57.]
2.6 Zirconium
Zirconium resembles titanium as it is a reactive metal in an oxygen environment,
forming a protective oxide layer on the surface of the material. Formation of this layer
happens spontaneously in air or in water at ambient temperatures and below it. Just like
titanium, this oxide layer heals itself when it is damaged. The oxide layer can protect
the material up to temperatures of 300 oC. The protective layer enables the metal to have
good corrosion resistance against mineral and organic acids, strong alkaline and saline
solutions. Zirconium's biocompatibility is superior to other stable metals. [14; 57.]
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Due to the corrosion resistance and biocompatibility properties, zirconium has been
used as an alloying additive in other metals like β-titanium alloys. Zirconium has also
been used for knee implants with a hard ceramic zirconium oxide (zirconia) surface that
is gained through heating the metal to 500 oC. The material has been Zr-2.5Nb alloy in
these cases with small additions of oxygen to increase the materials strength. Depth of
this layer is around 5 µm. After this depth, the material transitions to zirconium through
several micrometers. Zr-2.5Nb material has relatively low modulus out of the other
metal materials in medical applications, being at 100 GPa. [14; 57.]
2.7 Silver
Silver has been used in applications like structural devices that include cranial support
plates, suture wires, aneurysm clips and tracheostomy tubes. The metal has been used
also in prostheses like silicon-silver penile implants. Silver has an antimicrobial
tendency which is why it has been used as silver salts and complexes, which break
down to silver ions (Ag+), and also for polymeric coatings. Further development of the
material has been concentrating on the prevention of the growth of micro-organisms
responsible for diseases. [14.]
2.8 Electrical applications
Electrical applications are a subsection in the medical field that is recently growing.
Medical electrode applications mentioned with the tantalum metal section indicates a
role that metals have in electrical applications. Metals like tungsten, vacuum melted
type 316L stainless steel, cobalt alloys Elgiloy and MP35N, as well as pure metals like
zirconium and titanium are considered for these types of applications. These metals
have high mechanical strength and fatigue resistances that are demanded in
intramuscular electrodes. [14.]
Currently metals materials used for electrode applications are the noble or precious
metals like platinum, iridium, rhodium, gold and palladium. These materials are used in
devices meant for neural control implants like cardiac pacemakers, phrenic stimulators
for respiratory control, spinal cord stimulators for bladder control, auditory prostheses,
visual prostheses and neuromuscular prostheses for mobility of the limbs. These
materials have good electrochemical corrosion resistance even if each of them shows
some corrosion in vitro and in vivo in the electrical stimulation tests. Platinum and
platinum-iridium alloys containing 10 to 30 % Ir are the usual materials in use for
electrical stimulation. Other metal like tungsten are in consideration for more
demanding applications where the mechanical properties are also of importance. [14.]
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3 METALS AND ALLOYS FOR BIODEGRADABLE
APPLICATIONS
Metals tend to corrode under body environment and the degradation products are
usually toxic at least in large amounts when they do degrade. Due to these two reasons,
there are only two viable metal materials for biodegradable solutions in biomedicine
that are known. One of these materials is magnesium, the other is iron.
3.1 Iron alloys
Iron has been the first biodegradable metallic material used for implant purposes. Iron
has been used to manufacture stents even though the corrosion rate of the material still
needs some improvement. Iron's corrosion method is a localized one. The iron content
in the stent materials is over 99.8 %. The metal's property to interconvert between ferric
(Fe2+) and ferrous (Fe3+) ions by accepting and donating electrons readily enables it to
be compatible with biological reactions. This makes the metal ions useful for different
molecules like hemoglobin, myoglobin and many enzymes. Some research [50]  have
shown that metal does not completely degrade before the material is eventually released
to the blood stream. Excess amount of the material through degradation can still be a
negative aspect, though, which needs to be considered. [62.]
Iron's mechanical properties like high radial strength due to high elastic modulus
and ductility are considered beneficial for medical implants. High radial strength
enables easier manufacturing of stents with thinner struts and the ductility enables the
more gentle implantation. A few of the tested iron materials and alloys for stent
purposes are shown in Table 2. [26; 27; 51]
Table 2. Mechanical properties with in vitro degradation rate and average grain size for
different iron-based materials. [51.]
Material Yield
Strength
(MPa)
Tensile
Strength
(MPa)
Elongation
(%)
In vitro
degradation
rate (mm/y)
Average
grain size
(µm)
316L SS: annealed
(ASTM F138) [3]
190 490 40 _ 12-30
Fe: annealed [26] 150 200 40 0.19 40
Fe-35Mn alloy:
annealed [25]
230 430 30 0.44 <100
Fe-10Mn-1Pd alloy:
heat treated [62]
850-950 1450-1550 2-8 _ _
Fe-30Mn-6Si alloy:
solution treated [43]
180 450 16 0.3 <100
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Iron is a ferromagnetic material which makes it unsuitable for magnetic resonance
imaging (MRI). This can be changed with alloying elements like manganese with
content amount from 30 % and up. This type of alloying enables higher mechanical
properties that can be compared to 316L stainless steel. Manufacturing the alloy can be
done with methods like powder metallurgy and different rolling-sintering steps.
Degradation  rate  of  this  type  of  alloy,  though,  is  twice  as  fast  as  with  pure  iron.
Choosing the correct alloying element is thus a very important aspect when controlling
material properties. Processing also has an impact in controlling different properties for
the alloys. [26; 27; 51]
Iron can be manufactured and processed in many different ways, just like other
metallic materials. Vacuum induction furnace casting, heat treatments, rolling-sintering
steps and extrusion techniques are a few that can be used with iron. Iron can be alloyed
with elements like Manganese, Cobalt, Tungsten, Boron, Carbon and Silicon to improve
yield strength and ultimate tensile strength. Elements like Tin can lower the mechanical
properties of the iron metal if needed. Microstructure modification techniques like
electroforming processes causes finer microstructure of the material compared to other
techniques. This can increase properties like yield and tensile strength but at the same
time can lead to higher corrosion rates depending on the corrosion type, as the grain size
is smaller and the microstructure is orientated to columnar grains [26; 27; 51]. Just like
with NiTi alloys, certain iron based alloys with specific processing technologies can
create memory shape materials for different applications [43]. Iron's properties make it a
very promising material for biodegradable stents. Iron is not a good choice for electrical
applications since its conductivity is only 18% from coppers conductivity. [26; 51]
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4 MAGNESIUM AND ITS ALLOYS
Magnesium has been known for over two centuries now. Due to this fact, the material
has been used in many different application and studies in different fields. As
magnesium is used a lot, at the same time, it has shown its own problematic areas that
prevent it from being utilized in certain situations, for example for medical purposes.
4.1 Production of magnesium
Magnesium is the eight most abundant element in the Earth's crust and the fourth most
common in Earth, right after elements like iron, silicon and oxygen. Just like any other
metal material, magnesium needs to be extracted from the varying sources it is in before
we can use it for any applications.
Elemental magnesium was first discovered by Sir Humphrey Davy in England in
1808 by producing a mixture of magnesia and mercuric oxide. After Sir Humphrey's
discovery of the oxide version of magnesium, it took about twenty years until the metal
form of magnesium was isolated by a French scientist named Antoine-Alexander Bussy,
in the years of 1828 to 1831. Bussy did this by fusing magnesium chloride with metallic
potassium. In 1833, Sir Humphrey's assistant, Michael Faraday was able to produce
magnesium metal by electrolysis of fused anhydrous MgCl2. [6; 85]
In 1852 Robert Bunsen created a small laboratory for the electrolysis of fused
MgCl2. This was the start of commercial production of magnesium through electrolysis.
In 1862 magnesium was produced at a larger scale and the material was being used for
pyrotechnical and photographical applications. The world exhibition in London at that
time was one of the outlets that presented this new material to even wider audiences. In
the years of 1886 to 1940, several companies around the Europe and USA started
expanding the commercial production of magnesium through electrolytic production
and modifications of the Bunsen's laboratory cell method. Companies like "The
Aluminium und Magnesium Farbik" in Germany, "Chemische Fabrik Griesheim-
Elektron" the main producer of magnesium until 1916, American Magnesium Corporate
and the Dow Chemical Company enabled the wide use of the material during that time.
The large amount of companies around the world was due to the transportation
limitations and cost.  For medical studies and trials,  purity requirements resulted to the
use of the closest possible material provider. [85.]
4.1.1 Production methods
Magnesium does not exist in a metallic form in the nature but as in compounds.
Magnesium can be found for example in some ores like carbonates: dolomite
(MgCO3*CaCO3) and magnesite (MgCO3). Magnesium also exists in a compound
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named double chloride carnallite (MgCl2*KCl*6H2O)  that  is  found  in  salt  deposits  in
natural brines and evaporites. These can be found in the Great Salt Lake in Utah for
instance. The most common and abundant source for magnesium is ocean water as 0.13
% of the world's oceans contain magnesium. [6.]
One  of  the  first  ways  to  produce  magnesium  for  commercial  purposes  was  in  the
middle of the nineteenth century by using the Deville-Caron process. This method uses
potassium to reduce magnesium chloride in a heated closed container. First the
production was done to create wires or powders. Later magnesium was also produced
by electrolysis of the fused chloride. Currently there are about three different methods
for the production of magnesium metal. One of these methods is electrolysis of fused
anhydrous magnesium chloride (MgCl2) derived from magnesite, brine or seawater.
This method was used the most at least prior to the year of 2000, at an amount of 80 %
of the entire magnesium output of the world. The second method is the thermal
reduction of magnesium oxide (MgO) by ferrosilicon derived from carbonate ores. The
last method appeared in the 1990's, which uses electrolysis of fused anhydrous MgCl2
derived from serpentine ores. [6.]
The common electrolytic process that is used resembles the Dow seawater process
that is presented in Figure 2. Difference to the Dow seawater process appears in the
methods used to produce the anhydrous MgCl2.  The  difficulty  of  the  process  is  in  the
complete  removal  of  the  water  from the  MgCl2*6H2O compound. First four moles of
water can be extracted by heating it in the air so that the water evaporates. Further
heating after this will result to undesirable oxides and oxychlorides. The last parts of
water are difficult to remove. Methods to remove these two moles were created by
various companies. The water can be flashed off by adding small quantities of partially
dehydrated chloride which is added directly into a large mass of liquid mixture of
magnesium, sodium and calcium chlorides contained in the electrolytic cell in the
process. Another method uses dry hydrochloride acid (HCl) as an atmosphere to the
process and heat to dehydrate the compound. A different approach uses a cell feed of
dehydrated carnallite, which reduces the compound to a anhydrous form. [6.]
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Figure 2. Dow seawater process to produce magnesium ingots. [6.]
Producing anhydrous MgCl2 can be done by adding ethylene glycol to the solution.
The water is removed by distillation, which will produce magnesium chloride
hexammoniate by sparging with ammonia. This is then calcified to gain high-quality
anhydrous MgCl2. The solvents in the production method can be additionally recycled.
[6.]
The Magnola process, presented in Figure 3, uses serpentine ore as a source of
magnesium. The process is electrolytic as it uses magnesium chloride. The material in
this method contains magnesium silicate. This material is leached with a strong
hydrochloric acid in a specific process to produce MgCl2 solution, which is purified by
pH adjustments and ion exchange techniques. The result is concentrated ultra-high-
purity brine. This brine is dehydrated and used for electrolysis. [6.]
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Figure 3. The Magnola process. [6.]
Thermic-reaction processes can be used for the production of magnesium metal.
These processes are batch operations that are done in a vacuum environment and
generally use dolomite as the starting ore. Ferrosilicon is usually used as a reductant.
The process creates volatile magnesium, which distills off and is collected in a
container. One of these methods is the Pidgeon process presented in Figure 4. This
method uses externally heated retorts of relatively small diameter that each produces
about 120 kg of magnesium per day. [6.]
Figure 4. Pidgeon process to produce magnesium ingots. [6.]
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Alternative way for the Pidgeon process is the Magnetherm process, presented in
Figure 5. The difference is in that it produces a molten slag that can be then tapped off
without breaking the vacuum. The furnace is electrically heated internally and alumina
is used as a flux to reduce the melting point of the slag. Batch sizes of this method can
go as high as 11,000 kg. [6.]
Figure 5. The Magnetherm process. [6.]
These methods indicate the complexity of producing magnesium to metal form.
Other production methods also exist but the above mentioned methods are the most
common ones.
4.2 Properties of magnesium
Magnesium's mechanical properties can be considered beneficial in many fields.
Magnesium's light weight compared to other metal materials is a common reason for the
materials use. Magnesium's reactivity in corrosive environment is another factor that
has made it usual for corrosion protection for other materials.
4.2.1 Basic properties
Magnesium belongs to the alkaline earth metal group with elements like beryllium and
calcium. The atomic weight of the element is 24.3050 u and the volume is 14.0
cm3/mol. Magnesium is comprised of hexagonal close-packed unit cells in its structure,
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when the material is in its pure state under atmospheric pressure, presented in Figure 6.
Pure magnesium at 25 oC has almost perfect closed packed hexagonal crystal structure
with a c/a ratio (c and a can be seen from the Figure 6. (a)) of 1.6236 to 1.633. Heating
the material causes thermal expansion which changes this property at higher
temperatures. Slip reactions happen at room temperatures primarily on the (0001) basal
plane and in the [11-20] direction that is the most closely packed direction of the plane.
Secondary slip occurs in the [11-20] direction on the (10-10) vertical face planes. At
elevated temperatures slip will also occur in the [11-20] direction on the (10-11)
pyramidal planes. [6; 23.]
Figure 6. Magnesium's unit cell crystal: (a) Atomic positions in hcp structure, (b) Basal
plane, face plane, and principal planes of the [1-210] zone, (c) Principal planes of the
[1-100] zone, and (d) Principal directions. [6.]
Twinning, which is that two different crystal share a same crystal section, can occur
to pure magnesium at room temperatures across the (10-12) planes and secondary
twinning can occur across the (30-34) planes, according to Avedesian and Baker [6]. At
elevated temperatures twinning can additionally happen across the (10-13) planes
showing that heating the material affects multiple aspects of metal material structures.
[6.]
Fractures are common in metal materials. They can happen in different ways,
presented in Figure 7. For pure magnesium, at room temperatures and below, fractures
will occur mainly because of the joining of intragranular cracks that have formed on the
(30-34) twinned planes and on higher-order planes like (10-14), (10-15) and (11-24), by
a moderate amount of intergranular cracking. At higher temperatures cracking and
cavitation will generally happen at grain boundaries. [6; 57.]
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Figure 7. Metal material crystal structures that show point defects (substitutional or
interstitial elements, vacancies), line defects (edge and screw dislocations) and planar
defects (grain boundaries). [57.]
Mass characteristics of magnesium are an important aspect when creating
applications from the material. The density of magnesium is the lightest of all structural
metals which has made it a key material for applications that require light weight. The
density of pure magnesium at 20 oC is 1.738 g/cm3 [23]. Density has a linear tendency
when compared to temperature until it reaches the melting point. The melting
temperature of magnesium is 650 oC and the  density  in  that  point  in  the  solid  state  is
about 1.65g/cm3 and in the liquid state it is about 1.58 g/cm3. On cooling the volumetric
shrinkage of magnesium is around 5 %, when it is done from 650 oC to 20 oC. Linear
shrinkage on cooling is about 1.7 %. This shows that the thermal behavior of metals
needs to be taken into account when designing products. The melting point of
magnesium increases when the pressure increases. The increase is linear with the
increase in pressure in that in 10kbar the temperature is about 725 oC  and at 20 kbar it
is almost 800 oC. Boiling point for pure magnesium under atmospheric pressure is about
1090 oC. [6.]
Magnesium's thermal expansion coefficient of magnesium increases as the
temperature of the material increases. Thermal conductivity of magnesium peeks at
about -64oC. The values, though, for the material changes depending on the
temperature. Magnesium's magnetic properties are very weak. The relative magnetic
permeability (µ/µ0) of magnesium is 1.000012, which is near woods permeability.
Magnesium color due to its optical properties is bright silvery white. Table 3, presents
additionally some of the thermal, magnetic and optical properties of magnesium. [6.]
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Table 3. Thermal, magnetic and optical properties of magnesium. [6.]
Property Value Unit
Thermal conductivity (20 oC) 148-171 W/m*K
Enthalpy (formation of solid, 25 oC) 0 J/mol
Enthalpy (heat fusion, 25 oC) 32.7 ± 0.1 J/mol
Entropy (25 oC) 32.7± 0.1 J/mol*K
Specific heat capacity (20 oC) 1.025 kJ/kg*K
Latent heat of fusion 360-377 kJ/kg
Latent heat of sublimation (25 oC) 6113-6238 kJ/kg
Latent heat of vaporization 5150-5400 kJ/kg
Latent heat of combustion 24,900-25,200 kJ/kg
Magnetic susceptibility (Mg) +13.1 Xm/10-6cm3mol-1
Magnetic susceptibility (Mg(OH)2) -22.1 Xm/10-6cm3mol-1
Magnetic susceptibility (FeO) +7200 Xm/10-6cm3mol-1
Magnetic susceptibility (GdO) +53200 Xm/10-6cm3mol-1
Reflectivity (Mg, λ = 0.500 µm) 0.72
Reflectivity (Mg, λ = 1.000 µm) 0.74
Solar absorptivity (Mg) 0.31
Emissivity (Mg, 22 oC) 0.07
Absorption constant (λ = 0.589 µm) 4.42
Refractive index (λ = 0.589 µm) 0.37
X-ray absorption coefficient (µm) 32.9 m2/kg
Magnesium mechanical and other properties are presented in Table 4. The elasticity
of magnesium is different at different temperatures and changes linearly in the way that
the value is about 42 to 46 GPa at 100 oC and 37 to 39 GPa at  300 oC. The Poisson's
ratio for magnesium is 0.35 and the friction coefficient for magnesium versus
magnesium is 0.36 at 20oC. Surface tension of magnesium at temperatures of 660 to 852
oC range from values of 0.545 to 0.563 N/m. For temperatures at 894 to 1120 oC the
values range about 0.502 to 0.504 N/m. [6.]
Table 4. Mechanical and viscosity properties of magnesium. [6.]
Property Value Unit
Elastic modulus (dynamic,99.98% Mg, 20 oC) 44 GPa
Elastic modulus (static, 99.98% Mg, 20 oC) 40 GPa
Elastic modulus (dynamic,99.80% Mg, 20 oC) 45 GPa
Elastic modulus (static, 99.80% Mg, 20 oC) 43 GPa
Shear modulus 17 GPa
Dynamic viscosity (liquid Mg, 650 oC) 1.23 mPa*s
Dynamic viscosity (liquid Mg, 700 oC) 1.13 mPa*s
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Mechanical properties of magnesium metal changes depending on the processing
history that has been used. Tensile strength, compressive yield strength, elongation and
hardness values at room-temperature values with different processing histories can be
seen in the Table 5 and 6.
Table 5. Mechanical properties of unalloyed magnesium at 20 oC. [6.]
Form Tensile
strength
MPa
0.2%
tensile
yield
strength
MPa
0.2%
compressive
yield
strength
MPa
Elongation
in %
Hardness
HRE
Hardness
HB (a)
Sand cast,
13mm diam.
90 21 21 2-6 16 30
Extrusion,
13mm diam.
165-205 69-105 35-55 5-8 26 35
Hard rolled
sheet
180-220 115-140 105-115 2-10 48-54 45-47
Annealed
sheet
160-195 90-105 69-83 3-15 37-39 40-41
(a) 500kg load with 10mm diameter ball.
Table 6. Mechanical properties of magnesium in 20 oC, with different processing
histories. [23.]
Pure
Magnesium
Annealed
Sheet
Hand-Rolled
Sheet
Sand
Cast
Extruded PM-
Extruded
DMD-
Extruded
0.2%
Compressive
yield strength
(MPa)
69-83 105-115 21 34-55 92±12 (a) 74±4 (b)
0.2% Tensile
yield strength
(MPa)
90-105 115-140 21 69-105 132±7 (c) 97±2 (d)
Ultimate tensile
strength (MPa)
160-195 180-220 90 165-205 193±2 (c) 173±1 (d)
Hardness HB (e) 40-41 45-47 30 35 - -
(a) PM: powder metallurgy method, extruded at 350 oC, extrusion ratio 20,25:1,
(b) DMD: disintegrated melt deposition method, extruded at 350 oC, extrusion ratio 20,25:1,
(c) PM: powder metallurgy method, extruded at 250 oC, extrusion ratio 20,25:1,
(d) DMD: disintegrated melt deposition method, extruded at 250 oC, extrusion ratio 20,25:1,
(e) Using 10mm diameter ball and 500 kg load.
Magnesium's properties are highly dependent on temperature, which is seen from
previous values. The yield strength of magnesium is 130 MPa and density ~1.8 g/cm3,
which is close to the bone value of ~110 MPa and ~1.6 g/cm3. When compared to other
metallic materials like Ti-6Al-4V with corresponding values of ~970 MPa and ~4.50
g/cm3, it indicates that magnesium could be used as a non-stress shielding material for
bone healing applications. [6.]
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4.2.2 Corrosion property of magnesium
Corrosion has been generally considered a negative aspect when metals are designed for
stable applications under corrosive environment. Corrosion is the degradation of a metal
material that causes the mechanical and structural properties to fail. This can lead to
problems if the material is used in critical structural applications. Corrosion is also a
problem with magnesium metal, although, the problem has been solved in general use
by coatings and alloying the material. Magnesium's corrosion has not been, though,
solved in the medical field in implant use due to toxic alloying elements and coatings.
As the degradation property is a positive aspect for some medical implants, this is why
magnesium has also been studied for this kind of use. [84.]
Magnesium's corrosion effects have been studied after Prof. Dr. Erwin Payr started
to the material research for medical purposes in the 1900's. According to Payr and
Siegfried Vordemann, the studies on vessels and subcutaneous tissue revealed that
magnesium had severe influence on the tissue around the material. In the studies the
surrounding tissues had a large number of round cells and granulation tissue due to the
corroding magnesium. This granulation tissue had mucous consistence and foreign body
giant cells with metallic particles. These particles were also seen in leucocytes and the
granulation tissue was observed to be vascularized. Payr's studies indicated that the
corroding magnesium can cause severe blood clotting. Payr was one of the first
researchers to observe the corrosion of magnesium in a living tissue, according to Witte
[85]. Payr's studies indicated that the corrosion does not happen uniformly but by pitting
corrosion. His studies revealed that pure 0.1g magnesium piece can degrade completely
in three to four weeks in humans. Additionally, the location had distinctive effects and
that high-purity magnesium had a more uniform corrosion behavior in vivo than non-
pure magnesium. [85.]
Later studies by Höpfner [32], according to Witte [85] using anastomosis treatment
with dog vessels, supported the previous studies showing that the location of the
implant is important when considering the corrosion rate. The corrosion was faster in
the limbs due to the limb movement that enables more active blood flow. Wexler [78],
according to Witte [85] reported in 1980 that magnesium alloy wires with aluminum
can cause an increase in adrenal glandular weight, thymic involution, depression of the
abnormally elevated blood pressure and a retarded gain in weight with operated rats.
Certain serum enzyme levels of creatine phosphokinase (CPK), serum glutamic-
oxaloacetic transaminase (SGOT), serum glutamic-pyruvic transaminase (SGPT) and
lactic dehydrogenase (LDH), and corticosterone and deoxycorticosterone secretion were
reported to become elevated due to the use of this kind of alloy. The circulating levels
of triglycerides and cholesterols were reduced. These two studies [32; 78] already
showed the importance of knowing the corrosion of the material. [85.]
Magnesium does not corrode much in ambient environment as it gains a protective
oxide layer to it. Unlike some of the other metals, the oxide layer on magnesium is not
as protective as it is unstable and can easily be destroyed. The oxide layer can also be
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created through heat treatment. In a solution environment the corrosion of magnesium is
fast due to the degradation of the oxide layer. [103.]
In a solution based environment the metal releases Mg2+ ions due to the surrounding
solution and other ions. The pH of the solution has been reported to have a major effect
on the corrosion tendency of the material as higher pH results to the formation of a
passivation layer of MgO and Mg(OH)2, presented in Figure 8. The MgO layer has been
found out to be constant in thickness of about 2.5 nm and the outer Mg(OH)2 layer to be
variable in the range of 2.2 nm to several nanometers more [29; 95]. The passivation
layer on the surface of the material is created in a stable pH of 11 or higher solution. It
has been suggested that a solution of NaOH can effectively create the MgO/Mg(OH)2
layer. The protective layer can slow down the initial corrosion rate of the material. If the
solution has Cl- -ions or the solution is a buffer solution then the layer is destroyed due
to the pH stability at a lower level. [1; 29; 58; 95]
The degradation rate of magnesium is, additionally, highly dependent on the
concentration of HCO3- ions in a solution. Higher concentrations of HCO3- enhance the
degradation of the material. It also creates a protective layer which lowers the total
degradation rate of the material significantly. Xin et.al [89] have reported that about 27
mmol/L  of  HCO3- should be present in SBF solutions to acquire more accurate
corrosion results. [88.]
The potential of magnesium also has an effect as magnesium is nobler in water than
in simulated body fluid (SBF) [76; 95]. During the corrosion process, magnesium
releases hydrogen bubbles (H2) from the surrounding solution, presented in Figure 8
[29; 95]. The release of the hydrogen has a negative effect to surrounding tissue as it
can cause cell death. On the other hand, this corrosion tendency has been used in
studies as a positive aspect by Payr [56] according to Witte [85]. Different solutions
have been reported to have different effect on the degradation rate of magnesium. Pure
Mg has  a  lower  potential  of  -2.37  V when compared  to  -1.53  V for  Mg(OH)2, which
explains the protective nature of the layer. [96.]
Figure 8. Corrosion of Magnesium metal (Mg2+) in water creating a passive interlayer of
Mg(OH)2 or MgO on the degradation surface. [96.]
The fast rate of corrosion in solutions containing chloride ions can change the
surrounding pH level of the solution to 10. This can happen in a 250 ml neutral Hank
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solution in a 15 hour time span. This kind of reaction can lead to alkaline poisoning in a
body environment due to high amounts of metal material released to the surrounding
tissue. [68.]
Lespinasse [40] found out in 1910, according to Witte [85], that since the corrosive
environment  has  an  effect  on  the  Mg  corrosion,  the  in  vitro  and  in  vivo  studies  gave
different results for the corrosion rate. Andrews in 1917 [2], according to Witte [85],
revealed that the surface area is more important for the corrosion rate than the materials
weight/volume for in vitro and in vivo studies. Different studies [2; 19; 49; 55] have
resulted in different corrosion rates with different animal species, according to Witte
[85] and Song [68]. This has made comparisons between different study results
difficult. Heinzhoff's and Dimitroff's study in 1928 revealed that limited local fluid
exchange, gas exchange and autolytic changes in blood have a factor in the corrosion
rate, according to Witte [85].
Corrosion rate is also dependent on the oxygen content [16] of the blood and protein
presence [93]. The local hydrogen carbonic acid content has an effect due to the
formation of magnesium carbonate on the material surface. In a bone tissue
environment a carbonate layer is formed on the material surface which slows the
corrosion rate of the material. Magnesium phosphate can also be formed in to the
surface of the magnesium material in a bone tissue environment or in a solution where
phosphates are present. Additionally, in a environment that contains phosphates the pH
increase can enable the formation of a hydroxide apatite layer to the surface of the
material. This type of apatite layer does not form if the corrosion rate is fast and a large
amount of magnesium ions are released in a short period of time. [83.] Fontenier's et. al.
[17] revealed in 1975 that the composition of the corrosion layer stays very much the
same with different magnesium metals. The layer was determined to be about 60 % of
phosphates (likely MgNH4PO4*6H2O, 20 % of MgCO3, 10 % of Mg(OH)2 and 10 % of
CaCO3). [85.]
Magnesium can experience a degradation rate of 19-44 mg/cm2/day in an area of 1
cm2. The hydrogen release rate was determined to be around 25 ml/day. This hydrogen
release rate has been reported to be too fast. [68.] The typical magnesium aluminum
alloy that is used in different industries has the rate of hydrogen formation at a 1.5
ml/cm2/day level. For AZ91D material (Mg-9Al-0.5Zn-0.5Mn) the rate is about 0.068
ml/cm2/day. Alloying can thus decrease the degradation rate. The mentioned
degradation rates are still too fast due to the hydrogen release that creates gas pockets
on the areas of implantation. The gas can disappear after a few weeks when the
hydrogen release is 0.068 ml/cm2/day which means that the rate is very close to an ideal
level. The study [68] indicates that the body can remove the hydrogen at a certain rate.
The rate of hydrogen formation for a safe implant use has been suggested to be around
0.01 ml/cm2/day. According to Song [68], human blood plasma can tolerate magnesium
from 85- to 121 mg/L. These results have been gained by the use of hot distilled water
as sterilization to gain the Mg(OH)2 protective layer prior to implantation, alloying or
other protective layer use. Studies also indicate that larger animals and humans tend to
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be able to dissolve the gas cyst areas and degraded magnesium particles effectively
when compared to small animals. The degradation rate of the each material in vitro
tends to be higher than in vivo. [68.]
Some magnesium alloys that have been reported to have low degradation rates are
not actually preferable as implant materials due to biocompatible and toxicity problems.
Aluminum for example can be used for biostabile material applications but for
biodegradable applications it is not recommended. Choosing the correct alloying
elements is thus important for biocompatibility. Elements like calcium, zinc, manganese
and low amounts of rare earth elements like yttrium can be tolerated but toxicity test are
important to perform with magnesium alloys. Increasing the purity of the magnesium
material can be used to lower the corrosion rate of magnesium to an acceptable rate.
High purity magnesium, though, has low mechanical properties and machinability when
compared to alloy versions. [68.]
Due to the difficulties of solving the degradation rate of the material, several studies
in the recent years have been made, according to Xin et.al. [88]. Some of the
degradation studies are summarized in Figures 9 and 10. Due to the variation between
the studies, the results are very difficult to compare. Processing is a very influential to
the corrosion rate of magnesium, which has been noticed by multiple researchers
including Bonora et.al. [7] study about stressed magnesium alloys, Sun et.al. [70] study
about extrusion drawn pure magnesium, Wang et.al. [75] study about the bio-corrosion
of a magnesium alloy with different processing histories, and Xu et.al. [91] study about
chromium and oxygen plasma-modified magnesium.
Figure 9. In vitro degradation of magnesium alloy samples in different solutions. [4; 70;
71; 76; 83]
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a)   b)
Figure 10. In vivo degradation of magnesium alloy implants in different animals. [42;
82; 99]
An alternative way of indicating the degradation compared to the surface erosion
depth rate of the magnesium samples is through hydrogen evolution from the solutions.
This way of indicating the degradation, is through hydrogen evolution from the
solutions. The degradation rate comparison is different here, since the degraded
magnesium is presented as a volume of hydrogen. The method, though, is a more
accurate method as the degradation causes hydrogen release. Degradation rate estimates
through weighting the samples can give false results due to the formed oxide or
phosphate layers if they are not removed prior to weighing. Stating the degradation rate
through hydrogen release is usually preferred as the hydrogen release rate is more
prominent for the success of in vivo tests. Both results can be converted to each other
but hydrogen evolution samples can be additionally weight. A hydrogen evolution study
by Gu et.al. [21], which consisted of multiple different alloys in a SBF and Hank's
solutions can be seen in Figure 11. The results were from a 250 h time period. Mg-1Al
(as-rolled)  results  are  not  seen  due  to  too  high  degradation  rate  before  the  100  h  time
point. The degradation rate is an estimate from the results during the test period as the
degradation rate was almost linear for the samples. The degradation rate, though, is
higher at the start of the test, which is why these values are not accurate for the first 12
hours.
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Figure 11. In vitro hydrogen evolution results from magnesium alloy degradation in
SBF and in Hank's solution environments. [21.]
Processing effects seen in Figure 11 indicate that a more uniform, refined and
compact material with smaller grain sizes structure can withstand degradation more due
to smaller amount of defects and pitting corrosion locations [5]. The degradation rates
are evidently different between materials and processing methods when comparing the
results seen in Figures 9, 10 and 11. The in vitro solutions are fixed to certain ions and
changed  periodically,  thus  they  do  not  have  similar  ways  of  buffering  the  pH  change
compared to in vivo.
Tissue response to degradation
Magnesium is an essential element in the human body to its functioning. Magnesium
has been reported to be important for over 300 different reactions as it is a substantial
intercellular cation. Magnesium is also very important for the health of the human heart,
and for the maintenance of blood pressure and blood sugar levels. It has been reported
that the systemic toxic level of magnesium is about 7 to 10 mmol/L in serum. [85.]
Magnesium's corrosion rate, though, is very high which can lead to overloading the
surrounding tissue with the material and leading to neointimal formation. The high
degradation rate combined with the neointimal formation tendency at high rates can
cause restenosis to blood vessels if the material is used as a stent material. [85.]
The surrounding tissue can respond to the degrading magnesium in different ways
depending on the tissue type. Tissues like bone have been studied by researchers like
Lambotte [38; 39], McBride [49], Nicole [52] and Nogara [54], according to Witte [85].
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Lambotte's studies have indicated periostal proliferation progresses with magnesium at
3 to 7 week time before returning back to normal. Lambotte claimed that the material is
able to enhance bone regeneration, when on the other hand Zierold [104] stated the
opposite. Verbrugge's study [74] resulted to bone marrow replacement by granulation
tissue and new bone without osteoclasts. His studies also indicate cystic cavities in the
newly formed bone tissue. McBride's study [49] found out that corrosion of the
magnesium material is slower in intramedullar pegs than in transcortical applications.
Nogara's study in 1939 [54] reported that the hydrogen gas cavity formation in the
surrounding bone tissue leads to a small amount of bone damage that eventually is
healed after the material is completely corroded. Nicole's studies also report favorable
degradation rates for magnesium in bone when compared to other environments and
that the metallic corrosion products from the material cannot be observed after a certain
period of time. Nicole's study [52] also indicated the usual fibrous capsule formation
with magnesium implants in other locations and the sponge like tissue formation due to
the gas cyst formation. [85.]
Studies done in the nerve and muscle tissue area by Dr. Wilflinseder in 1981 [79]
were inspired by Payr's studies [56] on haemangioma treatments, according to Witte
[85]. Wilflinseder's study [79] reported that even though the gas formation is present
with magnesium wires with diameters of 0.25mm and 0.50mm subcutaneously and
intramuscularly, the material does not have negative effects that prevent the material to
be used for haemangioma treatment. [85.]
It was noticed by several studies that the degradation of magnesium does not create
any severe infections to the surrounding tissue even in non-sterile conditions [38; 49;
52; 54]. Although, in non-sterile conditions, it has been reported that the hydrogen gas
formation can possibly lead to a reduced local immunity of the tissue and pose a higher
infection risk from other sources. [85.]
4.2.3 Electrical conductivity of magnesium
The electrical conductivity of magnesium is 38.6 % IACS to that of annealed copper
(100%, 5.8001*107 S/m) [73]. Magnesium's conductivity is about 2.2388*107 S/m.  A
comparison table of different materials with their electrical conductivity and resistivity
is represented in Table 7.
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Table 7. Comparison table of electrical conductivity and resistivity of certain materials.
[9; 10; 11; 12; 13]
Material Conductivity
(% IACS)
Conductivity
(Siemens/m))
Resistivity
(Ohm-m)
Aluminum (pure) 61.00 3.54E+07 2.83E-08
Aluminum (99.99%) 64.94 3.77E+07 2.66E-08
Aluminum (As Cast) 27.00 1.57E+07 6.39E-08
Aluminum (Stress Relieved) 30.00 1.74E+07 5.75E-08
Copper (pure, annealed) 100.00 5.80E+07 1.72E-08
Copper (Deoxidized, annealed) 85.00 4.93E+07 2.03E-08
Gadolinium 1.32 1.31E-06
Iron (pure) 18.00 1.04E+07 9.58E-08
Iron Ingot (99.9%) 15.60 9.05E+06 1.11E-07
Iron 304 (Wrought Stainless Steel,
annealed)
2.50 1.45E+06 6.90E-07
Magnesium (pure) 38.60 2.24E+07 4.47E-08
Magnesium (Cast) 15.00 8.70E+06 1.15E-07
Neodymium 2.68 6.43E-07
Titanium 3.10 1.80E+06 5.56E-07
Titanium (Ti-6Al-4V) 1.00 5.80E+05 1.72E-06
Zinc (Commercial Rolled) 28.00 1.62E+07 6.16E-08
Zinc (Die Cast) 25.00 1.45E+07 6.90E-08
The electrical resistivity for single crystals of magnesium at 20 oC is 45.3 nΩ*m
along the c-axis. The temperature coefficient at this temperature is 0.165 nΩ*m/K along
the a-axis and 0.143 nΩ*m/K along the c axis. Contact potential of the material is +44
mV versus saturated calomel electrode at 25 oC and -0.222 mV against copper at 27oC.
The electrochemical equivalent for the material is 126 mg/C and the standard electrode
potential is -2.40 V against hydrogen. Ionization potential is 7.65 eV for Mg+ and 15.05
eV for Mg2+. Electrolytic solution potential for magnesium is 1.63 mV against saturated
calomel electrode at 25 oC  in  an  aerated  NaCl  solution.  The  work  function  of
magnesium is about 3.61 to 3.66 eV. [6.]
The given values indicate that magnesium is not as good as copper or aluminum in
regards to pure electrical conductivity. Magnesium's density value, though, makes the
material very appealing for electrical applications as it is around one fifth of that of
copper. The degradation tendency of the metal has hindered the materials use as
electrodes and other electrical parts. The biocompatibility aspect of magnesium, though,
makes it very interesting as a possible biodegradable electrical material. Due to this
potential, studies have emerged to create a magnesium based device that could degrade
over time. A study done by Hwang et.al. [31] has already created a degradable circuit
out of magnesium, silicon and silk, presented in Figure 12 f). Another study done by
Sebaa et.al. [63] has tested if an electrically conductive polymer coating could be used
as a medium for conductivity and for slowing down the degradation rate of the
magnesium implant.
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4.3 Alloying, processing and coating
Alloying and processing techniques are used to create a specific form to a material.
They have an effect to the overall properties of a metal material. This can be a crucial
part for modifying a material for implant applications.
A few methods are used more actively with magnesium for medical studies than
others. Coating techniques are also important for magnesium as they can effectively
prevent degradation at the start of the immersion period.
4.3.1 Alloying of magnesium material
Alloying is a typical method to modify metals for different applications. Alloying is the
adding of certain chemical elements to the material to gain desired properties.
Magnesium is no different in this regard. Alloying can have a major effect on the
properties of the original material. Some of these changes can be seen in Table 8, where
a stent material of 316L stainless steel is compared to magnesium alloys.
Table 8. Mechanical properties of different magnesium based materials in comparison
to 316L stainless steel with in vitro degradation rate and average grain size for
biodegradable stent use. [51.]
Material Yield
Strength
(Mpa)
Tensile
Strength
(MPa)
Elongation
(%)
In vitro
Degradation
Rate
(mm/y)(a)
Average
Grain Size
(ym)
316L SS: annealed (ASTM
F138)
190 490 40 - 12-30
Pure Mg: as cast 20 86 13 407 -
WE43 alloy: extruded T5 195 280 2 1.35 10
AM60B-F: die cast - 220 6-8 8.97 25
ZW21: extruded 200 270 17 - 4
WZ21: extruded 140 250 20 - 7
(a) The degradation rate is calculated from potentiodynamic polarization test.
Mechanical alloying is based on the use of powder processing in a ball-mill. In the
ball-mill, the material is repeatedly welded and fractured as the powder undergoes high-
energy collisions with the balls. The powder, alloying powder elements and the balls are
inside jars that are placed inside the mill. The alloying process happens inside the jars
while keeping the mill intact of contaminants. A control agent like stearic acid is used to
prevent excess welding that forms of lumps of material. With magnesium, solid solution
hardening and precipitation hardening are the mechanisms that improve the mechanical
properties of the metal. This is based on alloying elements that create intermetallic
compounds with magnesium. These compounds have their own phases which influence
the microstructure of the material and which can be seen in the alloy. [23.]
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Alloying elements for improving magnesium can include elements like rare earth
elements and metallic elements like lithium, zirconium and calcium [30; 57]. Lithium
can be used to enhance ductility and formability of magnesium alloys as it changes the
lattice structure from hexagonal close packed to body-centered cubic one. Zirconium
can be used to grain-refine magnesium alloys, which has an effect to the grain boundary
strengthening. [30; 57]
The limiting factor in alloying with magnesium is the liquid solubility of the
element in molten magnesium and the interference between competing alloying
elements. Each alloying element, additionally, has different effects to the magnesium
material and to the overall alloy. [6.]
The change, that an alloy material causes to magnesium, needs to be known
extensively so that the alloy does not gain toxicity, the degradation rate is in reasonable
values  and  that  the  material  can  be  still  machined  in  a  decent  way.  Processing  of  the
alloy also has an effect to the end product, which is why it needs to be accounted for
when designing applications from the metal material.
Alloying elements
Aluminum is considered to be one of the most used alloying elements with magnesium.
Use of this material is due to its favorable influence on magnesium. Aluminum
increases the hardness, strength and castability of magnesium [23; 84]. Aluminum itself
is used in several implant studies and has shown good biocompatibility most of the
time. Some studies, though, report that the material has negative effects to the body and
to the corrosion resistance. High aluminum content increases the Mg17Al12 phase which
enhances pitting corrosion for the alloy. Studies also report that aluminum is related to
reduction in osteoblast [37] and osteoclast [60] numbers, and macrophage-related
muscle diseases [67]. High aluminum content in a serum can also cause harmful effects
to neurons and be linked to dementia and Alzheimer's disease [15]. High aluminum
content can also suppress cell growth on the material surface. This can be changed
through surface treatment though. [37; 60; 67]
Calcium improves the strength and creep resistance of magnesium. Calcium is also
used to assist magnesium's grain refinement and creep-resistance. Corrosion resistance,
thermal properties and mechanical properties are also improved by the addition of
calcium. With casting alloys, the material reduces melt oxidation and oxidation during
heat treatment process, and gives better rollability of magnesium sheets. Calcium can
only be added up to 0.3 wt% to magnesium. [23.] Calcium can be, though, used with
magnesium in composites. In these cases calcium can increase the corrosion resistance
of the magnesium metal with up to 5 wt% of calcium without increased cytotoxicity due
to formations of various layers that includes a calcium carbonate layer and magnesium
carbonate and hydroxide layers. [102.]
Copper is used to improve the room temperature and high temperature strength of
the magnesium metal. Copper just like aluminum is not a preferred alloying element
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with biodegradable materials in implant solutions. Additionally, additions of copper
cause lower ductility and corrosion resistance to magnesium metal. [23.]
Iron is a harmful alloying element with magnesium. Iron lowers magnesium
corrosion resistance even with small amounts and only up to 0.005 % is acceptable for
corrosion protection. [6; 23]
Manganese can increase the yield strength property slightly. It also improves the
saltwater resistance of certain magnesium alloys by removing iron and other heavy-
metal elements to harmless intermetallic compounds. The limiting factor for the use of
manganese is its low solubility to magnesium. The material is usually incorporated to
alloys that have aluminum in them. [6; 23.]
Molybdenum is an allying element does not alloy or interact with magnesium
properly.  Small  increases,  of  0.7  to  3.6  wt%  amount  molybdenum,  results  to
improvements in hardness, elastic modulus, and ductility with magnesium.
Molybdenum reduces the tensile strength of magnesium slightly. [23.]
Rare earth metals (RE) like yttrium are used to improve the high temperature
strength, creep resistance and corrosion resistance of metal materials. They reduce the
freeze  range  of  the  alloys  which  lowers  the  casting  porosity  and  the  weld  cracking
during processing. RE's high cost is usually the limiting factor of alloying them with
magnesium. [23.]
Silicon is used to increase the fluidity of molten alloys. It used with iron, though, in
electrical applications. Magnesium's corrosion resistance is lowered more than in the
case of pure iron alloying. [23.]
Titanium has a limited solubility interaction with magnesium which makes it
difficult to alloy. 2.2 to 4.0 wt% additions of titanium increases magnesium's yield
strength and ductility only by 0.2 %. Titanium does not create intermetallic compounds
in the magnesium alloy. [23.]
Yttrium has a high solid solubility in magnesium. This can be around 12.6 wt%,
[23]. Adding yttrium to magnesium enhances the alloy's high temperature strength and
creep performance with other RE materials [44]. Yttrium can additionally increase
corrosion resistance due to the formation of an yttrium based oxide layer on the surface
of the alloy. [6; 24.]
The alloy in the practical sections consists of about 10 wt-% of Gadolinium, 1 wt-%
of  Neodymium  and  1  wt-%  of  Zinc  which  is  why  these  are  reviewed  more  than  the
other alloying elements. The provided material amount was too small to determine
alloying effects when compared to pure magnesium. Understanding the alloying
elements is still preferable for result discussion as small additions of another element
can have a large effect for the metal.
Gadolinium
Gadolinium has been known for over one hundred years now as it was discovered by
J.C. Galissard in Geneva, Switzerland in 1880. The material is part of the lanthanide
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group and its abundance in the Earth's crust is about 7.7 ppm. Gadolinium is silvery
white in appearance and is ductile and malleable. It is very similar to magnesium in
appearance. Gadolinium reacts in moist air and forms an oxide coating. Reaction to
water is slow but happens and the material is soluble in acids. [45.]
Gadolinium is used as an alloying material with metals like chromium and iron to
improve workability and corrosion resistance. Gadolinium is, additionally, used to
manufacture magnets and electrical component. [45.]
Gadolinium's crystal structure is hexagonal close packed; the electrical resistivity at
20 oC is 134 µOhmcm and is ferromagnetic. The bulk modulus is 39.1 GPA, hardness is
55 Vickers, tensile modulus is 56.2 GPa, tensile strength is 193 MPA and the yield
strength is 179 MPa. Density for gadolinium is around 7.9 g/cm3. [45.]
Neodymium
Neodymium was discovered in 1885 by Baron Auer von Weisbach. The material is used
to produce permanent magnets and flints. Neodymium is also part of the lanthanide
group. The material is reactive in air and forms an oxide layer. This layer can spall away
easily revealing more metal to form the oxide layer again. Neodymium reacts slowly in
cold water but quite fast in hot water. The abundance of the material in the earth's crust
is around 38 ppm. [46.]
Neodymium  is  used  to  improve  the  tensile  and  compression  strength  of  the
material. This happens due to the solubility limits that it has with certain materials. The
material can form stable precipitates within the grain structures and at grain boundaries.
[46.]
Neodymium's crystal structure is hexagonal close packed. The electrical resistivity
is 64 µOhmcm at 20 oC. The bulk modulus is 33.3 GPA, hardness is 35 Vickers, tensile
modulus is 37.9 GPa, tensile strength is 172 MPA and the yield strength is 165 MPa.
Density for gadolinium is around 7.0 g/cm3. [46.]
Zinc
Zinc was discovered in the 16th century by Paracelcus. The material is used currently by
different industries. It is used as a galvanic coating on steel to prevent corrosion and in
alloys as a constituent. It is also used in zinc-base alloys for die-casting solutions and in
dry batteries, zinc oxide as a pigment for paints and as a stabilizer for certain grades of
rubbers and plastics. [48.]
Zinc is a brittle material. The material is abundant in the earth's crust at about 75
ppm and occurs as concentrated ores. Reactivity to air causes it to have a tarnished
surface. It also reacts with acids and alkalis. Zinc has the hexagonal close packed crystal
structure. The electrical resistivity is 5.96 µOhmcm at 20 oC. The bulk modulus is 69.4
GPA, hardness is 2.5Mohs and the tensile modulus is 104.5 GPa. Density for zinc is
around 7.14 g/cm3. [48.]
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Zinc increases the tensile strength of the magnesium material without reducing its
ductility [98]. Usually aluminum is with these alloys but in our study it is not present
and as was mentioned it is not preferable for biodegradable implants. Adding zinc to
magnesium, that has iron and nickel impurities, improves the alloys corrosion
resistance. [23; 35; 99.]
4.3.2 Processing methods
Due to magnesium being a metallic material, it has several methods available for
processing like sand casting, die casting, squeeze casting, spray forming, mechanical
alloying, powder consolidation, sintering, heat treating, spin forming, hot forming,
welding, and machining. There are also other techniques available. [6; 18; 23; 92]
Die casting is based on utilizing high-pressure when a molten metal material is
forced through a small gap to fill a mold of a wanted shape and size. The method is fast
but highly dependent on wall thickness, alloy type, flow distance and temperature of the
material. When the mold is filled enough with the molten material, a high pressure of 40
to 1000 MPa is used to solidify the molten material, remove any gas inclusions and
reduce the shrinkage that happens during solidification. Cooling rate for this method is
around 100-1000 oC/s, resulting in a fine-grained microstructure. The method is used
for variable of different products but usually for thin-walled parts. [23.]
Squeeze casting is divided between direct and indirect methods. Squeeze casting
itself combines forging and casting processes but very much resembles die casting in
the end. In direct method a molten material is poured into a mold. This mold is sealed
with the upper half of the mold. A high unidirectional pressure is used to solidify the
material. Preheat-temperature of the melt material, additions, infiltration speed,
infiltration pressure and spacing between fibers need to be accounted for to gain a
wanted result. Direct method is used for metal matrix composites, especially for fiber
forced ones. In indirect method, the molten metal is poured into the sleeve of the
equipment. The speed of the molten material is controlled more than in direct method.
The method has higher material loss and therefore limits its use in situations where
material is not abundant. [23.]
Powder consolidation (compaction method) is based on powder-pressing. This
method is being divided into two different methods that are uniaxial and isostatic
pressing. In uniaxial pressing, the powder is poured into a metal die cavity and pressed
to a piece by a single direction pressure. Uniaxial pressing is divided additionally to two
different compaction choices which are hot compaction and cold compaction. In hot
compaction the die is heated to a wanted temperature during the pressure compaction
process. The method uses inert gasses to avoid oxidation. In isostatic pressing, there is a
pressuring medium between the die wall and the powder. This medium is used to apply
uniform pressure from all directions. Isostatic pressing is divided two different sub
groups that are cold isostatic pressing (CIP) and hot isostatic pressing (HIP). Both
uniaxial and isostatic pressing have negative aspects to them that dictate which of them
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is used at a given time. Uniaxial is used for cheaper and larger pieces. Isostatic is used
to achieve uniform densification but at a higher cost and slower processing speed. [23.]
Mechanical disintegration and deposition method (MDD) is used to lower the cost
of spray processes. MDD method uses a mechanical device to disintegrate the molten
slurry before it is deposited. In normal spray processes the disintegration is done
through inert gasses. In MDD method, the molten slurry of desired material is mixed
mechanically to obtain uniform distribution. The slurry is released through a 10mm-
diameter orifice at the base of the graphite crucible. Using a mechanical device below
the crucible, at a preheated temperature of 1000 oC, causes the slurry to be disintegrated
to multiple uniform streams. These streams are deposited to their own metallic substrate
holders for ingot creation. [23.]
4.3.3 Coatings on magnesium
Improving the degradation properties of magnesium is a prevalent problem that needs to
be solved. One solution to this is the incorporation of a polymer or a ceramic coating on
top of the material or a modification of the material itself to form a protective layer. The
goal is to enable small places of the underlying magnesium material to interact with the
surrounding solution and degrade in a slower rate than a material without a coating.
Coating processes that have been used with magnesium include spray coating and dip
coating. [90.]
The idea of a coating being utilized as a protective barrier has been studied for a
while now with promising results. Studies from Wong et.al. [86], and Xu and
Yamamoto  [90]  indicate  that  different  types  of  polymer  coatings  can  slow  down
magnesium's corrosion rate. Wong et.al. [86] reported that utilizing a polymer coating
that consists of polycaprolactone (PCL) and dichloromethane (DCM) with low porosity
membrane (LPM) and high porosity membrane (HPM) coatings version. The coatings
improved the corrosion resistance of magnesium significantly with improvements to the
pH change of the surrounding solution and the cell growth to the material surface.
The study done by Wong et.al. [86] reported that a uncoated AZ91 magnesium
material has around six times more weight loss than with a low porosity membrane
sample and around two time higher weight loss than with a high porosity membrane
sample. The study also indicated that weight loss of the material was about 0.017 g of
magnesium ions after 60 days. The degradation rate is fast at the first few days but after
10 days its start to slow down. After 30 to 60 days the rate is becoming very minimal as
the weight loss is slowing down. With the coated samples, the weight loss stayed very
linear during the 60 days testing period and reached around 0.0025 g with low porosity
membrane samples and 0.0060 g for high porosity membrane samples. [86.]
The pH values from Wong et.al. [86] indicates that the weight loss is relatable to the
pH increase graphs that are attained from the measurements. The pH from the uncoated
magnesium material lowers resulted to an end pH of 8.2. With the low porosity
membrane  sample  the  pH  reached  a  value  of  7.6  and  the  high  porosity  membrane
sample reached 7.8 pH. The starting pH for the solutions was reported to be 7.2 pH,
39
which in turn indicates that there is a rise on the pH-values of the solutions. The
imaging results from the study [86] indicate that after 3 days the magnesium samples do
not have much mouse osteoblasts cell growth on the surface of the samples due to the
violent pH rise from the degradation process. With both membrane coated samples, the
cell growth was evident. [86.] A study by Witecka et.al. [80] reported that silanizing
AZ91 alloy with different silanes can improve the alloys cytocompatibility and cell
growth on the alloy surface.
Xu  and  Yamamoto's  [90]  study  concentrated  on  four  different  polymer  coatings
which  were  poly  (L-lactid  acid)  (PLLA)-high  molecular  weight  (HMW),  PLLA-low
molecular weight (LMW), poly (e-caprolactone) (PCL)-HMW and PCL-LMW. The
PCL-LMW coating caused the pitting corrosion depth for the magnesium material to be
three times larger than with a PLLA-LMW coating. The corrosion rates from the test
after 10 days indicate that the PLLA-HMW has the lowest corrosion rate out of the
tested coatings, which was around 1.7 µm/day. With PLLA-LMW the rate was reported
to be around 2.3 µm/day. For PCL-HMW the rate was around 3.0 µm/day and for PCL-
LMW around 3.8 µm/day. All of these values were lower than the uncoated magnesium
samples that had around 4.8 µm/day rate for the degradation. [90.]
Other coatings like PLGA, PLLA and micro-arc osidation/poly-l-lactid acid
(MAO/PLLA) composites have also been studied with magnesium metal, according to
Wong et.al. [86]. These coatings have been able to control the degradation of
magnesium based alloys. Other methods for coating on the magnesium surface have
been micro oxidation coatings, various Ca-P coatings and fluoride coatings. [86.]
These studies emphasize the importance of choosing the right type of coating
regulate the degradation rate of the underlying magnesium material. The pitting
corrosion type with the magnesium material can also have changes in its pitting
corrosion depth depending on which coating material is used. Problem is that there is
not enough relevant studies that indicate how well these coatings have attached to the
magnesium surface. Obtaining uniform nonporous coatings have been a problem and
the thicknesses of these coatings have not been reported clearly, which indicate the need
for more accurate and extensive studies with these methods. Each coating should be
thus considered differently and not discarded immediately. [86.]
4.3.4 Thin coatings from magnesium
Creating thing coatings from magnesium and for magnesium is a difficult process as the
metal tends to create a hydroxide layer easily in a moist environment or an oxide layer
when heated. These layers are brittle, yet beneficial when trying to lower the initial
degradation rates in implants.
Coatings can be formed to the surface of the magnesium metal at least in two
different ways. These include sputtering and electron beam evaporation techniques.
Sputtering has been studied by Ibasco et.al. [33] and Wu et.al. [87]. Ibasco et.al. [33]
studied a 3 µm thick magnesium coating on top of a titanium material by sputtering
technique. This coating was created from a 20 cm diameter metallic targets that were
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99.5 wt-% magnesium. Coated titanium pieces were sizes of 25.0 mm*25.0 mm*0.5
mm and they were rinsed with ethanol/acetone (50/50 wt-%) solution for 15 min. The
coated material study was immersed in different solutions containing KCl,
NaHPO4*7H2O, MgCl2*6H2O, K2HPO4 and NH4H2PO4 to study the creation of stable
phosphate precipitates. Immersion in ammonium diphosphate (ADP) formed struvite
crystals (NH4MgPO4*6H2O) in a few seconds, coating the material completely in a few
minutes. The study reports that the creation of a struvite coating on top of a titanium
material is possible. The coating is later replaced by a calcium phosphate layer (CaP)
that enhances cell survival and adhesion to the material when compared to pure titanium
material. It was also indicated that sputtering magnesium on top of material is possible
as the coating is firmly attached to the titanium material. The underlying coating layer
was determined to be MgO from the sputtering process. [33.] The effect of phosphate
coating has also been proven by Ishizaki et.al. [34].
Electron beam evaporation method was studied by Chowdhury and Kumar [8]. A
magnesium based films was created from MgO powder that was obtained from
magnesium ribbons by burning the magnesium material or by sol-gel technique. The
thin films were created on glass substrates that were the size of 25*25*1-3 mm. The
electron beam had a 6 kV gun and a ~10-5 torr pressure was used during the coating
process. Current was in the range of 60-80 mA for the evaporation. Deposition time for
the coating went up to 15 min in the study. The e-beam evaporation technique is based
on a magnetic field and electron beam use where the magnetic field directs the beam to
the powder material which is then deposited at a high speed to the substrate. The target
material itself is located in a ingot that is water cooled and the filament is away from the
whole process so that it is not contaminated but from which the magnetic field can
direct the beam correctly.  Some of the films were later annealed in different conditions
to determine the effect of annealing to the created coating. The study reported that e-
beam evaporation is a viable technique to create coatings of magnesium and that
annealing the surface causes the films to have different types of formations in them. [8.]
4.4 Applications consisting magnesium
Magnesium is the lightest structural metallic material. Due to this property, magnesium
has been used for different applications that require light weight. The degradation
property of the metal has prevented the metal to be used as the primary material for
medical and electronic applications when. This has not, though, prevented the study of
the material in these fields due to the positive sides the metal has.
The development of magnesium has concentrated on general applications outside of
the medical field which is reviewed now. Studies and development of the material in the
medical section is also an important part so that the history of the metal is known before
the practical part of the work.
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4.4.1 General applications
Magnesium has been used widely in different fields. One of the first applications that it
has been used was in pyrotechnics and photography. Other areas have been in
metallurgical, chemical, electrochemical and structural applications.
Pyrotechnics was the first application area of the material for wider use.
Pyrotechnical use of the material is due to the burning nature of finely divided powder
of magnesium-aluminum alloy containing over 30 % of aluminum. The powder burns in
a very bright white light. This aspect made the alloy desirable for photography
flashlights as it was more suitable for photography than natural light. The bright light in
some fine magnesium powders can cause damage to the eyes if the material was not
used properly. Other application for this light property has been in flares for night aerial
photography, miscellaneous fireworks, high-energy fuels and incendiary devices. [6.]
Magnesium is also used to manufacture nodular iron as it removes some of the
sulfur and spheroidizes the graphite from iron ore. Magnesium can also desulfurize steel
and be used as a deoxidizer in the manufacturing of copper-based alloys like brass and
bronze. Magnesium is used to improve the strength and corrosion resistance of metal
materials like aluminum through alloying. [6; 47.]
Magnesium can be used in the production of complex and specialized organic and
organometallic compounds. Magnesium is used in the production of magnesium alkyls
and aryls and as a neutralizer in lubricating oils. It can also be used in the purification of
argon and hydrogen gases. [18.]
Magnesium has, additionally, been used in electrochemical applications.
Magnesium and its casted and wrought alloy products can be used in for example in
cathodic protection, batteries and photoengraving. Magnesium can act as a sacrificial
galvanic anode to extend the working life of household and industrial water heaters;
underground structures like cables, pipelines, well casings, tanks, and tower footings;
and seawater condensers, ship hulls, ballast tanks, and steel pilling in marine
environments. Magnesium has also been used to construct batteries of dry-cell and
reserve-cell types such as seawater activated cells. [6; 47.]
As a structural metal material, magnesium has been used due to its lightness. This
has made it appealing for products that are carried, need lightness to reduce fuel
consumption or need of a light material for lifting or thrust power requiring aspects.
These applications include hand held device casings, laptop casings, car body parts, and
airplane and missile parts. Lightness also enables lower inertia for rapidly moving parts.
Magnesium's good elevated-temperature properties have also made it desirable for
aircraft, missile and oven applications. Fatigue strength in wheels, damping in
electronic housings for aircraft and missiles, dimensional stability in electronic housings
and in jigs, and fixtures have had preferable use with magnesium. [18; 23.]
These applications indicate the diverse use of magnesium. Limitations of the
material in the mind of the environment emissions and service forces that are applied to
the product need to be considered when creating products from magnesium. Aqueous
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environment in most cases is limited due to the corrosion tendency of the metal.
Magnesium importance in each of these applications is different. For some applications
the use of magnesium has lowered due to new materials as in the aeronautical market.
Currently magnesium's role in aeronautical applications has been in cast engines and
transmission housings for helicopters. In the automobile and hand held device market
that use of die casted magnesium products has been growing. This is due to fuel
consumption and the need for lighter hand held devices. Also magnesium's property to
shield from electromagnetic forces has been an important factor for electrical equipment
casings.
4.4.2 Medical applications
Edward C. Huse was the first to try the magnesium metal for implants, according to
Witte [85]. His tests consisted of wire ligatures to stop the bleeding of blood vessels in
three patients. These included one radial artery test and two varicocele operations.
According to Avedesian and Baker [6] and Witte [85], Huse discovered during these
operations that the material was able to stop the bleeding successfully but that the
degradation aspect of the material seemed problematic.
Following Huse's experiments in 1900, Payr studied tubular, thin-walled cylinders
made of magnesium for connecting vessel anastomosis, presented in Figure 12 a). Later
in 1924 Seelig started to experiment with pure magnesium as wire material. The wires
were produced from 99.99 % pure magnesium that were extruded and drawn to 0.005
inch and larger sizes. Seelig's studies resulted to similar low tensile strength results as
previous commercial grade magnesium wires had. The low tensile strength of
magnesium was overcome to some extend by Gotthard Gossrau in 1935 when he
patented  a  magnesium  rope  consisting  of  a  mesh  of  smaller  than  0.1  mm  thin  wires
around the inner stronger guiding wire or wire bundle. The outer wire mesh provided a
better attachment surface that is required by suture material with the inner material
having better mechanical property. Eventually, in 1986, Richard Jorgensen filed a patent
of modified haemostatic clip design that had inspiration from metal clip designs that
Andrews had published in 1917 for ligatures and deep sutures. Andrews designed
magnesium medical clips and staples were reported to be useful in closing vessels, deep
wounds and intestinal anastomosis cases.  The alloys were not suitable,  though, due to
toxicity or due to the mechanical properties were lacking for medical purposes in 1917.
These studies, though, created the ground work that is being continued currently. [85.]
Magnesium as a medical material has been studied extensively in the past already,
additionally to the people and tests mentioned earlier. In the Table 9, there is a summary
of some tests done by researchers from the 1870's to 1980's.
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Table 9. Historical table of some of the authors investigating magnesium for medical
purposes in chronological order. [85.]
Year Author Magnesium or
alloy
Application Human
model
Animal
model
1878 Huse Pure
magnesium
Wires as ligature Humans _
1892-
1905
Payr High-purity Mg Tubes, plates,
wire, rods
Humans Guinea pigs,
rabbits, pigs
and dogs
1903 Höpfner Pure
magnesium
Cylinders as
vessel connectors
_ Dogs
1906-
1932
Lambotte Pure Mg
(99.70 %)
Rods, plates,
screws
Humans Rabbits and
dogs
1910 Lespinasse Metallic
magnesium
Ring-plates for
anastomosis
_ Dogs
1917 Andrews Pure Mg and
Mg/Al, Mg/Cd,
Mg/Zn
Wires, clips as
ligature
_ Dogs
1924 Seelig Pure Mg
(99.99 %)
Wires, strips,
bands
_ Rabbits
1933-
1937
Verbrugge Mg-6Al-3Zn-
0.2Mn and
Mg-8Al
Plate, band,
screws, pegs
Humans Dogs, rats,
rabbits
1951 Stone Mg-2Al and
Pure
magnesium
Wires for clotting
aneurysms
_ Dogs
1980 Wexler Mg-2Al Wires
intravascular
_ Rats
1981 Wilflingseder Pure Mg
(99.80 %)
Wires for
hemangioma
Humans _
Payr studies in 1900 concentrated on repairing vessel anastomosis with magnesium
connectors. These test indicated that the vessel ends became attached and solid in 8
days. Payr's tests, additionally, indicated that the intravascularly placed magnesium
tubes enabled some thrombotic blood clotting at the end of the tubes but not to the point
of closing the lumen. Extravascularly placed tubes on the other hand did not cause any
thrombosis on the blood. Similar results were found by Höpfner in his own studies after
Payr. Höpfner's cylinder studies were based on Payr's designs but modified to some
extent. Höpfner noticed, though, that the thrombosis effect was present only in vessels
of less than 3 mm diameter and even in these cases because of extensive intima lesions
during operations. With larger vessels, Höpfner did not notice thrombosis with dogs
even after 4 weeks of study. Later in 1910, Lespinasse studied with extravasal sutures
and magnesium ring plates for anastomosis repair [40]. He found out that the ring plates
degraded completely after 80 to 100 days. The original shapes of the rings were
maintained for about 30 days before clear breaking down happened. In the 1920's to
1950's,  Seelig studied the use of magnesium based wires for aneurysm treatment with
rabbits. He found out that alloyed magnesium wires with aluminum resulted in higher
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thrombosis chance than with stainless steel wires. With pure magnesium wires he
noticed the brittle nature of the material to be a problem. Seelig reported collagenous
tissue formation around the wire and the intima for attachment. The alloyed magnesium
wires showed fast degradation in 21 days. [85.]
The study of musculoskeletal area with magnesium materials started with Payr's
suggested possibilities of using plates and sheets in joint arthoplastics. His studies with
animal and clinical experiments, unfortunately, did not have positive results but they did
inspire others to study the subject more. One of these researchers was Chlumský, who
studied magnesium for regaining motion in stiff joints. Chlumský's animal studies
concentrated on knee joints of dogs and rabbits, by using 0.1-0.8 mm thick sheets. His
tests revealed that these sheets degraded in 18 days to few weeks depending on sheet
thickness. During these studies he was successful in preventing joint stiffness. His
experiment extended to a human case eventually and was able to preserve a 2 mm wide
joint space even after 8 months from the operation. [85.]
In 1909, Lambotte [38] experimented magnesium implants with a 17 year old child
who had over a year old fracture on the lower leg. Lambotte decided to use magnesium
based plates with iron wire and steels screws. This unfortunately, though, resulted in
extensive subcutaneous gas cavity formation, swelling and pain after one day.
Lambotte's discovery resulted him to research more of the matter with his assistant
Verbrugge.  Lambotte's  experiments  continued  for  some  time  with  animal  tests  and
eventually with increasing test cases to humans. He reported that even, though, the
magnesium degradation does cause gas formation, it was not a problematic or painful as
the gas cavities disappeared after a few weeks. He eventually understood that the
problem was the combination of other metallic materials that resulted to a higher rate of
electrolytic  corrosion  in  his  first  test  with  the  child.  His  studies  also  resulted  that  a
magnesium screw in a supracondylar fracture healing treatment had degraded
completely after one year of the operation without any hypertrophic bone. These results
eventually made him recommend the material for certain bone healing areas like carpus
fractures, lower arm diaphyseal fractures, humerus head fractures, malleolus fractures
and others. This recommendation was also shared by Heschen and Gerlach in 1934. [85]
There has been, though, conflicting results. In 1913, Groves discovered abscess
cavities and too fast degradation of the material for implants. In 1924, Zierold had the
same opinion and concluded that magnesium is only a connective tissue stimulant,
theorizing that the material is promoting but at the same time retarding new bone
formation. [85.]
Verbrugge's work was continued by McBride in 1938 [49] with plates and screw,
presented in Figure 12 b). McBride's studies showed that the material was not suitable
in certain types of applications as plates showed a too fast degradation rate and with
medullar pegs the gas formation became a problem because it was not able to exit into
soft tissue. McBride concluded in his studies that magnesium does create a local
disturbance even if the material is not toxic, and that the material is mostly suitable in
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cases where the absorption of the material is needed and where the stress of the
fragments is slight after a few weeks. [85.]
In 1940, Maier was investigating magnesium pins made of spindle-shaped sheets.
Maier reported that there were no clear healing processes seen and the gas cavity
formation was too large for the safety of the patient. What he noticed, though, was that
the functional results were good after 14 years which resulted him to study more about
the material with animal tests. His recommendation was to use magnesium for
arthorodesis of joints and in spinal surgery. In 1948, Troitskii and Tsitrin experimented
an Mg-Cd alloy for plate and screw applications. They reported that the material
stimulated the formation of callus bone which was due to the formation of MgCO3 in
the corrosion layer. The use of this type of alloy was suggested for rod and plate use for
severe osteomyelitis cases. The patent for improving the corrosion resistance of
magnesium by alloying it with Cadmium, which enabled faster recovery of patients,
happened in 1969 by Stroganov. [85.]
Payr's and Martina's studies also extended to operating a 54 year old woman's
cancerous gall bladder with significant parts of the liver. The bleeding tissue was
stopped by using magnesium plates with iodine-catgut sutures. In their previous studies
with animals, they had noticed that the degrading magnesium material caused the
hydrogen bubbles to penetrate the extensive fibrous tissue around the material and stop
the local bleeding by a tamponade effect. After two weeks, the fibrous tissue formation
slowed with the 54 year old woman. [85.]
Payr's has also suggested magnesium to be used for treating cavernous
haemangioma and large-vessel aneurysms. Payr's idea of destroying the haemangiomas
and lymphangioma tumors with magnesium pieces, presented in Figure 12 c). This was
based on the principle of enhanced blood clotting in the tumor area through the metal's
degradation. Payr later summarized that this method only seemed to work with
subcutaneous cavernotic haemangioma. This method was later tested again in 1981 by
plastic surgeon Wilflingseder [79] with 27 different haemangioma patients.
Wilflingseder's clinical results showed that about 50 % of the cases were treated
successfully. [85.]
Magnesium's suitability in medical implant applications have seen some doubt even
in the researchers own study periods as was seen with Chlumský at  one point.  He had
reported at one point that the material is not suitable for intestinal anastomosis treatment
but after seeing Payr's work he saw that the purity of the material has a impact on the
suitability. He reported that high-purity magnesium corrodes homogenously in vivo and
that it is more suitable even though the connectors were significantly corroded after 8
days to a few weeks depending on the location. [85.]
Magnesium has also seen some studies regarding it being as a suture material,
presented in Figure 12 d). The metal has also been suggested for connectors for
neurography and for biobatteries for pacemakers. Studies have reported that magnesium
can  be  used  as  a  suture  material  but  only  as  an  alloy  due  to  the  brittle  nature  of  the
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metal. Magnesium has been studied extensively based on these researches. Figure 12
presents some of the applications that metal material have been used in.
Figure 12. Researched magnesium based medical applications. a) Tubal magnesium
connector designed by Payr for vessel anastomosis [85], b) Mg-Mn plate for rotation-
resistant osteosynthesis by McBride [85], c) Magnesium rods for haemangioma
treatment by Payr [85], d) Lekton Magic's expanded WE43 magnesium alloy coronary
stent [51], e) Mg-4Y alloy screw for joint reconstruction surgery [95] and f)
Biodegradable transient electronic silk sheet with magnesium and silicon based
structure [31].
As the medical and implant field has been moving towards biodegradation
products, magnesium's unique tendency to degrade as a metal has made it an interesting
choice for certain application. The biocompatibility of the material has resulted to recent
studies that are concentrating on applications like blood vessel stents, bone healing
products and electrical electrodes, according to Li and Zheng [41]. The degradation rate
of the material is still though unsolved. Studies done by Guan et.al. [22] about Mg-Zn-
Sr alloy, Johnson and Liu [36] about Mg-Y alloy, Salahshoor and Guo [61] about Mg-
Ca, Shadanbaz et.al. [64] about calcium phosphates on magnesium, Tang et.al. [72]
about calcium phosphate/titania coatings on AZ31 magnesium alloy and Yu [94] copper
containing carbon films on magnesium alloys are only a few of the new studies done to
solve magnesium's problems. When these aspects are solved, it can mean huge
possibilities and novel ideas to the implant field.
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5 Mg-ALLOY's DEGRADATION AND
CONDUCTIVITY STUDY.
The practical work centered on the idea of testing a magnesium alloy, to determine if a
polymer coating could be used to lower the degradation rate of the magnesium alloy.
The modification and preparation methods that the material needs were also in a focus
to evaluate if the original material shape could utilized for powder creation.
Degradation tests are focused on pH measurements that are used to calculate mass
and hydrogen release rates for the alloy material. The mass is also measured through
weighting the samples to determine if the calculation results can be used accurately.
Alternative approaches to how future testing could be done are discussed at the end.
5.1 Materials
The material provided for the study was a magnesium based alloy. The alloy consisted
of 88wt-% of Mg, 10wt-% of Gadolinium (Gd), 1wt-% of Neodymium (Nd) and 1wt-%
of Zinc (Zn).  The material  amount provided for testing was 6 grams of the alloy from
the supplier.
The pieces all were different shaped with a similar form from cutting processes for
other purposes. These pieces can be seen in Figure 13.
Figure 13. Provided material pieces for testing purposes.
The original pieces were cut with a utility knife as the material tended to break quite
easily through bending and cutting forces. The pieces were also grinded between two
files two obtain small particle sizes. Particle forming resulted to four different particle
size groups for further testing. These groups were achieved by using sieves of different
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hole diameters that resulted on size groups of >500 µm, <500 µm, <315 µm and <125
µm. The groups had alloy of about 1.808 g, 1.336 g, 0.586 g and 0.076 g respectively.
Weighting was completely done in each phase with a "GWP Mettler PM400" weighting
machine. The machine has a ±0.002 g error range for its readings.
The preparation and test phase also had a polymer material that was poly(l-lactide-
co-dl-lactide) (PLDLA) 50:50 powder.
5.2 Composite preparation
A "Nike Hydraulics Type ZB110" compression machine, presented in Figure 14 a), was
used to achieve similar composite pieces. During the composite formation the
compression pads were heated to around 150 oC. Compression during this preparation
was done so that it did not exceed 10 MPa of compression force. Cooling was done by
either water or air, depending on if the water cooling was an option at that time.
a)  b)
Figure 14. Nike Hydraulics Type ZB110 compression machine and molds used for
composite forming.
Two different molds were used during the compression processes to get the needed
composite pieces. First mold was a simple compression pads seen on the right of Figure
14 b). These compression pads were used to create flat polymer pieces that were cut into
narrow strips that were able to fit into the mold seen on the left of Figure 14 b).
After acquiring the narrow polymer pieces from the compression and cutting
process, the weighting machine was used to divide the pieces so that each composite
sample had similar amounts of polymer. The magnesium amounts were not measured
due to the difficulty of controlling them during the composite forming. This was due to
the static electricity of the material.
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Polymer pieces of 50*10*1.0 mm size were created with the molds. A small indent
of 25*4*0.5 mm size was created onto the middle are of the polymer pieces. This indent
was then filled with the magnesium alloy to mildly contain the alloy during the
composite formation. Polymer pieces without the indent were placed on top of the
polymer and magnesium material. This was then compressed together to create a solid
composite piece that had the magnesium alloy generally in the middle of the polymer
material.
5.3 Samples
Composite formation resulted to 10 composite pieces and 6 pure polymer pieces.
Samples named Mg-PLDLA-s (surface) were composites where the polymer did not
cover the magnesium material properly. Mg-PLDLA-e (embedded) named composite
samples had polymer covering almost completely the magnesium alloy. PLDLA named
samples had only polymer material in them. 6 magnesium particle samples and 4
original magnesium piece samples were, additionally, chosen for testing. Magnesium
samples were named as Mg and 2 original samples were named as Mg-Original.
Composite, particle and 2 original samples were used for testing the degradation in a
“Sørensen” buffer solution. Two other original pieces were named as Mg-Original-
water and were used for degradation testing in de-ionized water environment.
Magnesium amounts were weighted so that they generally were in the same weight
range for getting similar results. Result from the composite and particle sample
formation can be seen in Table 10.
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Table 10. Test samples and their material amounts.
Diameter Magnesium Polymer: Total Ratio
Sample: Size (µm) Weight (g) Weight (g) Weight (g) Mg/polymer (%)
Mg-PLDLA-s 1 >500 0.083 0.283 0.366 22.7 / 77.3
Mg-PLDLA-s 2 >500 0.090 0.302 0.392 23.0 / 77.0
Mg-PLDLA-s 3 <500 0.142 0.292 0.434 32.7 / 67.3
Mg-PLDLA-s 4 <315 0.060 0.282 0.342 17.5 / 82.5
Mg-PLDLA-s 5 <315 0.065 0.282 0.347 18.7 / 81.3
Mg-PLDLA-s 6 <125 0.031 0.268 0.299 10.4 / 89.6
Mg-PLDLA-e 1 >500 0.040 0.464 0.504 7.9 / 92.1
Mg-PLDLA-e 2 <500 0.056 0.462 0.518 10.8 / 89.2
Mg-PLDLA-e 3 <315 0.049 0.425 0.474 10.3 / 89.7
Mg-PLDLA-e 4 <125 0.039 0.415 0.454 8.6 / 91.4
PLDLA-s 1 0.292
PLDLA-s 2 0.294
PLDLA-s 3 0.296
PLDLA-e 1 0.456
PLDLA-e 2 0.429
PLDLA-e 3 0.434
Mg -1 >500 0.070
Mg -2 >500 0.099
Mg -3 <500 0.045
Mg -4 <500 0.107
Mg -5 <315 0.056
Mg -6 <315 0.070
Mg-Original 1 Original 0.076
Mg-Original 2 Original 0.097
Mg-Original-
water 1
Original 0.085
Mg-Original-
water 2
Original 0.085
For PLDLA samples the s and e letter at  the end of the name refer to the polymer
amount that is similar with the composite samples. This was done so that any effect of
the polymer could be seen in the results.
5.4 Testing methods
Testing was focused on a simple resistivity test by using a "Fluke 112 True RMS
Multimeter" machine, pH measurements by using a "Mettler Toledo SevenMulti"
machine with a ±0.002 pH error range. A microscope was used to monitor the samples
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visually during the hydrolysation testing by “Zeiss West Germany”, camera part was
“BestScope” and a light source was “Schott KL1500”.
The buffer used in our test samples, except for the two Mg-Original-water samples,
was a “Sørensen” buffer created from 15.48 g of Na2HPO4,  3.3 g of KH2PO4 and de-
ionized water to get 2 liters of 7.48 pH buffer solution. Each sample was placed inside
of test tubes with 30 ml of buffer or de-ionized water, depending on the sample. The
30ml amount of liquid was chosen based on the 1:30 ratio that is used for hydrolysis
tests as there was less than 1 g of material for each sample.
During  the  testing  period  the  pH  of  the  samples  was  measured.  The  pH
measurements were done during a four week time period in room temperature of about
(19-22 oC).  The  buffer  was  changed  to  samples  that  had  higher  pH  at  190  hour  time
point when compared to their pair in their magnesium particle size. Another buffer
change happened at 528 hour time point, which was done to the samples that had the
previous buffer change. Composites samples of Mg-PLDLA-s 1, Mg-PLDLA-s 3 and
Mg-PLDLA-s 4 had the buffer changed due to these reasons. Magnesium samples of
Mg-2, Mg-4, Mg-6 and Mg-Original 2 also received a buffer change. Buffer change
was, additionally done to polymer samples of PLDLA-s 1, PLDLA-s 3 and PLDLA-e 1
to make sure the polymer does not have any real effect on the pH. De-ionized water
sample of Mg-Original-water 1 got a solution change at 144 hour time point and the test
period for the samples was 624 hours long. Mg-Original-water 2 sample had a test
period of 480 hours and no solution change.
Wet weight of composite and polymer samples were done 672 hour time point after
the first immersion to the solutions. Microscope and camera pictures were taken from
key  areas  of  the  samples  at  before  the  start  of  the  pH  tests,  after  190  hours  from
immersion and at the end of the hydrolysis test. Dry weights were measured after the
hydrolysis test was over. Composite and polymer samples we dried for 24 hours and
magnesium samples were dried for 72 hours.
Due to the limit of just weight measurements and pH change results, calculations
from  the  pH  change  results  were  done  to  determine  the  degradation  amounts  that
samples could relatively have. The buffer solution can prevent some material from
being seen from the actual pH-changes, which is why its effect was calculated.
The degradation reaction that takes place happens according to formula (1) [95].
Presence of buffer can add reactions to the process which can be seen in formula (1)
[24; 88] with the potassium phosphate reaction.
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The degradation calculation can be done by according to the formula (2). The
concentration of the buffer element is the same amount as magnesium's. This is because
the buffer can neutralize both hydroxide ions that evolve from the magnesium's
degradation.
][*)()(
][][
03,0*)2/]([][
)(/)(][
222
03,042
2
24203,042
4242242
+++
+
=
=
=
=
MgMgMMgm
POKHMg
POKHPOKH
POKHMPOKHmPOKH
L
LL
L
(2)
The mass change results from the pH changes can be calculated by using formula
(3). The phosphate and hydroxide concentrations are multiplied by 0.03 to get the
correct amount of ions in the test tubes (30 ml of liquid).
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Calculations to determine the hydrogen release of the sample materials were also
done. As with the mass loss calculation, calculation of the hydrogen release was done
first due to the buffer effect. Calculating hydrogen gas release is done through volume,
which can be done according to the formula (4).
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(4)
In formula 4 the R is the gas constant that is 0.08314510 bar*dm3/(mol*K), P is the
air pressure in sea level that is 1.01325 bar and T is the temperature from the lab room
which was about 21 oC (294.15 K). Volume from the buffer effect can be calculated
according to formula (5).
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Calculating the released hydrogen from pH change is done according to formula (6),
when the buffer effect is minimal and the pH rises. The calculation is based on both
formula 3 and 5 calculations.
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The resistivity tests were done by using a "Fluke 112 True RMS Multimeter"
machine. Original alloy pieces that were not used for composites were used to
determine if the alloys resistivity can be measured. Additional measurements were done
with the particles gained from the particle forming process.
Imaging was done with the microscope at three different time points for most of the
samples with magnifications of 0.8, 3.2 and 6.4. Imaging was done at room temperature
(20-22 oC). Composite and polymer samples surface were dried lightly before imaging
with a soft tissue paper. Each composite sample was imaged before the start of the
hydrolysis test. The second time point for imaging was done at 190 h after immersion of
the  test  samples.  Third  time point  was  done  at  the  end  of  the  hydrolysis  test  at  672  h
after immersion. Mg-Original-water 1 sample had the imaging done at 144 h time point
after immersion with a camera. Both Mg-Original-water samples were imaged at the
end  of  the  test  at  624  h  for  Mg-Original-water  1  and  480  h  for  Mg-Original-water  2.
Additionally, other magnesium samples in the test tubes were imaged with a camera at
the 190 hour time point.
5.5 Results
Testing concentrated to a 4 week testing period of hydrolysis tests in the test tubes. The
pH measurements during the time period provide the degradation information for later
discussion and calculations.
Calculations were done to determine the mass loss and hydrogen release of the
samples. These results were, additionally, compared to pH results and weighting results
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to determine if the calculations are the effective way to determine the degradation of the
samples. Figures from imaging provided further insight to the degradation.
5.5.1 pH results
During the first few hours of immersion to de-ionized water and buffer, magnesium
creates a very active reaction with the solution. The reaction from formula (1) indicates
that the degradation releases hydrogen. The hydrogen evolution started immediately
after immersion to the solutions. This can be seen as hydrogen bubbles forming from
the sample surfaces and rising to the surface of the solution. The hydrogen bubbles
tended to lift the samples to the surface of the liquid in the test tubes due to the very fast
activation of degradation in each magnesium sample and in some of the composite
samples. This results in some parts to not have contact with the liquid. Therefore, the
test tubes solutions were mixed each time this had happened to make the samples sink
to the bottom of the test tubes. The pH tests results can be seen in Figures 15, 16, 17 and
18. Buffer and solution change can be noticed from the Figures due to the drop in pH to
the level of the buffer, except for the polymer samples.
Figure 15. The pH-change for the composite samples containing 10-32 % of
magnesium. Magnesium had poor coverage by the polymer.
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Figure 16. The pH-change for the composite samples containing 8-11 % of magnesium.
Magnesium had good coverage by the polymer.
Figure 17. The pH-change for all the magnesium samples.
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Figure 18. The pH-change for all the polymer samples.
The pH results from the degradation reactions indicate that the degradation is more
active in de-ionized water than in the buffer solution. This of course is not the situation
since the de-ionized water has no buffer capability. For Mg samples the buffer effect
lasts for about 24 hours from immersion. In water the pH can rise up to 10.60 pH in a
few hours, which is why the buffer limit is reached fast. The composite samples indicate
that the degradation rate is lower due to the polymer preventing the solution from
touching the magnesium material.  The pH rise of composite samples containing 10 to
30 % magnesium is more clear due to the insufficient coverage of the polymer material.
This  yields  some  of  the  magnesium  to  react  with  the  surrounding  buffer  and  thus
increase the pH of the solution. Composites containing 8 to 11 % magnesium seem to
have lower degradation rates as only a few sites seem to be degrading due to the poor
coverage from the polymer. Polymer sample results indicate that the polymer does not
contribute effectively at to the rise or fall of the pH of the solution. Some fluctuation of
the pH happens in the tests, which might be contributed to temperature, ion imbalance
of the solution at the testing time and equipment errors. Additionally, the results
indicate that the material amount and particle size have an effect to the degradation
amount. Particle size of the magnesium samples has an effect to the degradation amount
due to available surface area. The larger material amounts with some samples can cause
the alloy to be tightly submerged preventing the larger surface area to have an effect on
smaller particle sizes.
From the presented results the pH fluctuates with most of the samples between a
given day’s first reading and the second reading (3 h later). This can be explained by the
temperature difference between the test times. The temperature did not change most of
the  times  between  these  test  points  but  at  some  points  the  difference  was  0-0.5 oC.
Temperature changes between days ranged from 0-2 oC due to the change in the lab
room. More prominent reason for the pH change can be caused by an uneven
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distribution of the ions in the solution. This was noticed some of the times when the pH
changed due to the movement of the sensor and the solution around it. The last reason
could be contributed to the reactions mentioned in formula 1. These reactions remove
the free hydroxide ions from the solution to water or to the surface of the magnesium
material. The Mg(OH)2 layer formation was noticed in the magnesium samples in the
de-ionized water as their pH started to decline after 24 hours. The formation of the
protective layer slows down and can even prevent the degradation when the solution is
in a pH range of 9-11.
5.5.2 Mass change results
The wet and dry weights of the composite, polymer and magnesium samples were
measured with the measuring machine. These results can be seen in Figures 19, 20 and
21.
Figure 19. Wet weight mass change for all the composite and polymer samples.
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Figure 20. Dry weight mass change for composite and polymer samples.
Figure 21. Mass change for magnesium samples after 72 hours of drying.
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Results indicate that the weight changes only slightly with composite samples and
most cases they can be considered to be close to the error margins of the measuring
equipment. Wet weights show the importance of drying but also indicate that the
equipments error margin can have an effect. For example, the PLDLA-s 2 sample has
higher weight increase after drying. This may also indicate impurity problems during
measurement. Some polymer sample results indicate that a small amount of solution is
still trapped in them as they have higher mass than at the start. This indicates that the
drying  period  was  not  long  enough.  This  applies  to  the  composite  samples.  Mass
variations can be caused due to degradation of the material, additions of phosphate layer
and the intake of solution. The intake of solution, degradation of magnesium and
formation of phosphate layer might then indicate that they can balance the weight of the
samples for the first few weeks. This makes degradation measurements difficult when
using the weighting method. The mass increases of Mg samples are due to the
phosphate layers presence, which is important to be removed before evaluating the mass
change for magnesium samples. The increase in mass for magnesium samples is also
difficult to estimate when including the phosphate layer as during the drying period,
some of the phosphate material is stuck in the container/test tube walls and are thus left
out  from  the  weight  measurements.  Mg-Original-water  samples  did  not  have  the
phosphate layer and as such did not have any clear mass change. Change can be
contributed to the measurement devices error range and the fast addition of hydroxide
layer.
5.5.3 Calculation results for degradation
The buffer effect calculated according to formula (2) results to about 8.8 mg of
magnesium. Once this amount is degraded the pH starts to rise according to formula 3.
After this point the mass loss results are added to the final amount of degradation. The
mass change results from the calculation of formula (3) and (6) were done to each
sample.
The buffer effect calculated according to formula (4) results to about 8.8 ml of
hydrogen gas. The loss of hydrogen from the solution is balanced by the reaction that
occurs from the buffer effect. During the buffer solution, a loss of about 2 ml of solution
was noticed. This loss can be contributed towards the hydrogen release and the pH
testing where the sensor takes a small amount of solution with it when the calculation is
done. Once the buffer effect is diminished the pH starts rising. The hydrogen release
results from the calculation of formula (6) were done to each sample that contained
magnesium. This was done to determine the correlation between the hydrogen evolution
to the mass loss. Both mass loss and hydrogen evolution results are shown in Figures
22, 23, 24 and 25. Mass loss of polymer samples from the calculations can be seen in
Figure 26.
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Figure 22. Mass loss and hydrogen evolution for composite samples containing about
10-32 % of magnesium. Magnesium had poor coverage by the polymer.
Figure 23. Mass loss and hydrogen evolution for composite samples containing about 8-
11 % of magnesium. Magnesium had good coverage by the polymer.
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Figure 24. Mass loss and hydrogen evolution for magnesium samples including the
Mg-Original-water 1 and 2 samples submerged in de-ionized water.
Figure 25. Mass loss and hydrogen evolution for magnesium samples without the
Mg-Original-water 1 and 2 samples submerged in de-ionized water.
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Figure 26. Mass loss for the polymer samples.
Based on the calculation results, magnesium's degradation amount with magnesium
and composite samples that have noticeable pH increase is around 8.8 mg. This
degradation amount happens during the buffer effect. The mass loss during pH rise in a
buffer solution is a low amount that does not change this value in a significant way. The
mass loss from the calculations indicates that the degradation in the buffer (8.8 mg) is
more active than in de-ionized water (0.00014-0.00017 mg). This is due to the pH
staying longer below the 9 to 11 range. For de-ionized water samples, the pH rises fast
to 10.5-11 pH area. This hinders further active degradation and enables the formation of
the protective layer, which lowers the mass loss values that are seen in Figure 24. The
buffer solution thus keeps the solution in the area that benefits further degradation of the
material. Additionally, due to the buffer solution containing phosphates, the surface of
the magnesium materials starts to gain a phosphate coating, according to formula (1).
The degradation amount after buffer change, when the buffer is limiting the pH rise, is
difficult to estimate due to the degradation of the protective layers. The phosphate layer
can be noticed without a microscope as it forms a white crystal type of structure around
the magnesium metal. This increases the sample weight which explains why the wet and
dry weight measurements do not reveal clear decrease in weight when compared to
calculation results.
These results indicate the correlation between pH increase to mass loss and
hydrogen release amounts. The maximum amount of hydrogen release from the
calculations is not accurate as the decrease in the value does not mean hydrogen gain
outside  of  the  solution.  The  amount  can  be  estimated,  though,  to  be  around 8.8  ml  of
hydrogen gas as the evolved amount during pH rise is low compared to the evolution
during the buffer effect. For samples in de-ionized water the hydrogen amount is around
0.14-0.17 ml. These results do not provide enough information to determine if the
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material  is  suitable  or  not  for  implant  applications.  They  do,  though,  indicate  that  a
certain amount of degraded magnesium in milligrams can release the same amount of
hydrogen gas in milliliters. Accurate degradation measurement should be done through
the ratio towards a surface area which was not done to the samples in this test  due to
random sized pieces and different particle sizes.
The pH readings indicate a slightly steeper rising curve for the samples after the first
buffer change when compared to the curves after the second buffer change. With
calculation results of mass loss and hydrogen evolution this is not seen so clearly as
change in pH is based on a logarithmic scale. This means that a pH of 10 has ten times
as much [OH-]  ions  than  a  pH  of  9,  resulting  to  ten  times  higher  mass  loss  for  the
degradation. This can be noticed with the Mg-Original-water 1 sample in Figure 24 as
the maximum degradation amount after solution change is around four to five times
lower than in the start of the test, due to pH level being lower by 0.5 units.
The degradation curve change after buffer change is not completely due to a sudden
fast degradation of the sample material. The change is due to the degradation of the
protective layer around the sample and the sample itself. Due to the change of the buffer
and the lower pH due to it, the hydroxide and phosphate layers start to degrade which
again releases the magnesium, hydroxide and phosphate materials to the solution. This
in turn raises the pH much faster when compared to the original degradation rates before
buffer change. This happens mainly with the first buffer change as the protective layer
is not as complete as before the second buffer change. This leads to a situation where
the normal magnesium degradation and the hydrogen evolving from it can destroy the
layer easily. With the second buffer change, the layer is more complete and can thus
prevent the degradation more readily. These reactions indicate that the pH, mass loss
and hydrogen release results are not quite accurate as some of the material hydroxide
ions from the degradation process are bound to a coating and sometimes these ions
(from the coating) are released back to the solution. These eventually, give us lower
degradation results for samples where the buffer was not changed and higher
degradation results for those of which buffer was changed.
5.5.4 Results from the conductivity tests
The conductivity and resistivity tests done with the "True RMS Multimeter" machine
revealed two aspects for these kinds of tests. The original material pieces gave about
0.2-1.0 Ω resistance readings from a 1 cm long material section. Due to the varying
sample sizes for length and diameter size, as well as not uniform diameter in the pieces
themselves, the materials conductivity values cannot be estimated. This applies to the
varying particle size samples as the device does not provide readings unless the particles
are pressed to create a proper contact between each particle piece. The readings with the
powder samples ranged from 0-8 Ω depending on how much the material was pressed
together. More force applied resulted to a lower reading. The readings also indicate that
obtaining accurate reading can only be done from a solid piece that would have a fixed
uniform diameter and length.
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5.5.5 Imaging results
Imaging was done with a camera and a microscope to determine whether there were
visual degradation effects. Two different composite samples from before immersion,
after 190 h and after 672 h are presented in Figure 27. The degradation in both samples
is happening in the materials surface as the material has lost some of its shine. The
change is more noticeable in Mg-PLDLA-s 5 as it had less polymer covering the
material. The degradation, especially with the sample Mg-PLDLA-e 4, is localized. This
is referring to the pitting corrosion reaction of the alloy. This degradation is indicated in
the figure using the arrows. The polymer covering these samples does prevent the
solution from touching the metal completely which is why both of them experience
degradation.
a)  d)
b)  e)
c)  f)
Figure 27. Degradation images of composite samples. a) Mg-PLDLA-e 4 before
immersion, b) Mg-PLDLA-e 4 after 190 h, c) Mg-PLDLA-e 4 after 672 h, d) Mg-
PLDLA-s 5 before immersion, e) Mg-PLDLA-s 5 after 190 h and f) Mg-PLDLA-s 5
after 672 h. Arrows indicate localized degradation.
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The localized corrosion in the areas influenced by the solution is more noticeable in
sample  Mg-PLDLA-e  4.  With  Mg-PLDLA-s  5,  the  corrosion  is  more  uniform  due  to
higher exposure to the buffer solution. The samples were imaged with the same
brightness in at a given time. This indicates that the surface of Mg-PLDLA-s 5 has
degraded more and lost its shine. The degradation behavior was noticed more in Figure
28. These two locations indicate how the magnesium can degrade if it is directly in
contact with the surrounding solution. The degraded area is thought to experience
excessive degradation which results to extensive hydrogen release. The hydrogen can
cause localized areas where the degradation can happen even faster which can explain
the cracks in the materials surface. Additionally, these cracks might be explained by the
fact that metal degradation tends to happen more easily in defect areas and in grain
boundaries. The cracks later disappear due to the complete corrosion of the surface area.
a)  b)
Figure 28. Degradation images of composite samples. a) Image section Mg-PLDLA-e 2
after 190 h and b) Mg-PLDLA-s 5 after 190 h. Arrows indicate localized degradation.
The formation of the phosphate layer can also be noticed through imaging. This
layer creates a crystalline structure over the magnesium material. This can be seen in
Figures 29, 30 and 31. The layer can be detected by the human eye and can cover the
magnesium material completely if given enough time.
a)  b)
Figure 29. Degradation images of composite samples. a) Image section of Mg-PLDLA-s
1 and b) Mg-PLDLA-s 3 after 190 h. Arrows indicate locations of phosphate layer.
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The phosphate layer can form around the material in a few days and continues to
form until it covers it completely. After the layer has covered the material, it does not
grow larger in a way that it could be noticed through imaging during the testing period.
a)   b)
c)   d)
Figure 30. Degradation picture of magnesium samples. a) Mg-Original-water 1 after
144 h, b) Mg-Original 1 after 190 h, c) Mg-1 after 190 h and d) Mg-6 after 190 h.
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a)  b)
c)  d)
Figure 31. Degradation picture of magnesium samples. a) Mg-Original-water 1  after
624 h, b) Mg-Original 1 after 672 h, c) Mg-1 after 672 h and d) Mg-6 after 672 h. Each
sample was dried for a 72h period.
Figures 30 and 31 reveal that the magnesium powder and original pieces in the
buffer are formed in different forms compare to the Mg-Original-water 1 sample. This is
due to the phosphate layer that covers the samples. During the degradation, the
hydrogen release causes the magnesium to move with the hydrogen unless the hydrogen
bubbles are shaken away from the material. This movement causes the pieces and the
powder to not stay on the bottom of the test tube. As the phosphate layer starts to form
during this process, it prevents the magnesium to have a compact form resulting into the
shapes seen in the figures. This enables the alloy to have a larger amount surface to be
in contact with the solution. This in turn enables a larger phosphate layer formation
which can give higher weight results for weigh measurements.
5.6 Discussion
The benefits that can be attained when the corrosion problem of the magnesium material
is solved are immense. Creating biodegradable metallic implants that could be used for
temporary solutions due their mechanical, structural and production advantages with
biocompatibility. The use of such material could mean alternative choices for bone
healing products, where the material actually has a very close mechanical property to
the bone [69].
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Creating biodegradable electrical applications are also a potential side for metallic
implants. This aspect could be used for temporary sensors, drug releasing applications
that need some control but a specific release site and even applications for temporary
tracking devices if needed in certain situations.
To obtain a biodegradable magnesium material, a few solutions have been
presented. Improving the material purity is one but generally results in the lowering of
mechanical properties of the material when compared to alloyed options. Increasing the
material purity also results to a material that is harder to manufacture to a certain size
and shape. For electrical applications, pure magnesium could be used in terms of
mechanical properties but the corrosion rate is too high if it is not remedied by coating
choices. Alloying has be another way to solve the degradation problem.
Biocompatibility has been a problem though. The complexity of choosing a suitable
alloying element for magnesium alloys has been difficult. All of the possibilities,
advantages and disadvantages of the material have caused the recent interest for further
study.
The metal combination in the practical study was considered to be created due to
improving the corrosion resistance of the material and its machinability, without
compromising the materials biocompatibility. The material amounts in the alloy stay in
the limits of alloying with magnesium. The material amount provided for testing was 6
grams of the alloy from the supplier. The low amount of material created difficulties for
preparation and testing. This meant that careful preparation was necessary without
having too large material losses.
The shape of the alloy resulted to the need of forming the alloy to a different shape
for testing. The usual form for degradation and other tests are either solid known size
pieces or powders. With metals, melting the material and then solidifying it to a solid
piece is a possibility. This would then be grinded to a powder if there is a need to it. For
alloys, melting is not an option unless the alloying process for the metal material is
known.  Knowing  the  process  and  the  steps  would  enable  the  replication  of  the  alloy
when creating the solid pieces. This information was not known for this research. Due
to this,  options were limited to cutting and grinding the alloy to a powder form as the
original piece shape was more difficult to use for composite forming.
Powder forming with this material type was challenging due to the shape of the
material and the mechanical strengths that it holds. The pieces are small and difficult to
handle. The mechanical properties prevented the use of different types of mill
equipment in the university. Ball mill equipment that uses hammering of the material to
smaller pieces would increase the mechanical strength of the alloy due to metal
hardening. Cutting mills did not work due to small amount of alloy and the shape of the
material  resulted  it  to  stick  to  walls  of  the  equipment.  Additionally,  the  purity  of  the
equipment was a consideration for later testing in mind. Lowering the properties with
liquid nitrogen was tested unsuccessfully due to the alloy having too large resistance to
forces even in lowered temperatures. Grinding the alloy with a single file that is used in
some studies was difficult due to the shape of the material.
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Cutting the material with utility knife was time consuming. This kind of method is
not recommended with large material amounts. Preventing material loss is also difficult
as it gets easily flown due to high forces of the method. The other method that used two
files created various particle shapes due to material breaking. The method is slightly
faster than cutting but still time consuming. Using the two files method also causes the
files to grind each other which releases file material to the powder. This material needs
to be removed. One way to do this is by using magnets as the file material is highly
magnetic. The file material is possible to be removed from the powder with magnets but
there is some material loss as parts of the alloy is magnetic due to the alloy metal
additions. Completely removing the file material from the powder material is difficult,
though, which takes time and may not be complete due to small sizes of the powder.
The overall material amount at the start of the particle formation was 4.829 g which
resulted into about 1.023 g of material loss. Decision to use less than the full amount of
material at hand was made so that the rest could be used for various testing purposes to
save the powder material until the final methods for testing were decided. The material
amounts indicate that the preparation methods are not optimal as one fifth of the
material is lost due to various problems of the methods.
The polymer used for composites has a degradation tendency towards bulk
degradation. The degradation, though, can change towards surface degradation due to
the  presence  of  Mg(OH)2 which stabilizes the poly(L-lactide) structure through
neutralization of the acid microclimate pH of the polymer, according to Mobedi et.al.
[50]. Degradation rate is also lowered in this case if the pH of the polymer and the
surrounding solution stay in neutral range. Higher pH increases the degradation rate of
the  polymer.  The  goal  of  using  the  polymer  was  to  observe  the  influence  of  the
surrounding polymer to the magnesium alloy's degradation rate.
Both materials were provided in plastic bags or containers. This was determined to
be a preferred method of storing these materials, at least in the case of magnesium. This
is due to the alloy material's susceptibility to static electrical forces. These forces cause
the alloy to stick to the plastic bag or any surface that cannot discharge the material.
Handling of the alloy was thus done with metallic or glass based materials.
During the composite forming, the magnesium ratio to the polymer amount was
difficult to keep the same. This resulted to the large amount of magnesium towards the
polymer  amount  in  samples  Mg-PLDLA-s  1,  Mg-PLDLA-s  2  and  Mg-PLDLA-s  3
when compared to the other samples. Due to the irregular magnesium amounts, the test
results are not completely accurate for proper test results.
The hydrolysis test could not be done in a heating oven in this study as the samples
released hydrogen that might cause problems to other samples or the equipment. The
testing  period  for  the  study  was  determined  due  to  interest  in  the  first  month  of
magnesium degradation as other studies have focused more on the long periods of
hydrolysis tests that are the more common and appropriate ways of doing these tests.
Test results indicated that the polymer can lower the degradation rate of the
magnesium alloy. Degradation difference between de-ionized water and buffer solution
70
reaction was also noticeable with the results. The formation of a phosphate layer was
noticed and indicated that the layer prevents further degradation of the magnesium
material. With composite samples, the phosphate layers formation is not complete for
the whole alloy or composite. The reason is that the whole magnesium alloy amount in
the composite sample is not completely in touch with the buffer solution. This enabled
the pH of the surrounding buffer solution to rise as more of the alloy becomes in touch
with the buffer. These results indicate that a coating can be used to limit the rate of the
magnesium degradation. The degradation type and rate of polymer is thus important to
obtain a low enough degradation rate for magnesium metal.
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6 CONCLUSION
Magnesium is a very promising material according to the research done in the medical
field. The degradation problem of the metal has been studied for over one hundred years
now. Several methods have been suggested to either improve the material itself through
improving its pureness, alloying the material with other metals or through coating the
material. Each method provides a different way for the same problem. The most
promising way to combat this property is through alloying and coating of the material.
Alloying can improve the degradation resistance of the metal and improve the
mechanical properties of it. Coatings, on the other hand, delay the degradation process
of the material and can enable small amounts of the metal to degrade at a given time if
chosen correctly. Literature review section resulted that releasing the degradation
information should be done with different values. Reviews should use hydrogen release
method if possible because of the formation of Mg(OH)2 and phosphate layers. These
layers can give false reading to the amount of degraded magnesium if they are not
removed with appropriate solutions like mild acids. Mass loss results can be thus used if
done properly.
The practical work reported that the Mg-10Gd-1Nd-1Zn magnesium alloy in testing
is reactive as other magnesium alloys in a solution environment. This alloy was coated
with a PLDLA 50:50 coating that slowed the degradation rate of the material when
compared to magnesium samples. Additionally, the buffer had a significant effect to the
pH  development  of  the  solutions  when  compared  to  de-ionized  water  samples.  The
buffer solution also enabled the magnesium material to gain a phosphate layer that
covered it almost completely after 600 hours.
The tests results indicate potential for the alloy and for the composite type in
question. Further studies would be needed for this alloy type to determine if it is
suitable for implant solution or if it is too fast to degrade. Longer period of hydrolysis
test is also needed with these test to see how long does it take for the material to start
degrading more completely with composite samples. Additionally, cytotoxicity tests are
needed to determine if the alloy still retains the biocompatibility of the magnesium
metal. The hydrogen release effect on cells around the composite samples needs to be
also tested if the degradation rate is suitable. To obtain proper hydrogen and mass
release data about this material also means that the materials samples need to have a
fixed size that is known and which can be related to the common (ml/cm2/day) way of
informing the hydrogen release rate.
The conductivity tests, additionally, resulted that the material form was not suitable
for  these  kinds  of  tests.  This  indicates  that  multiple  samples  of  same  length  and
diameter are needed to make proper estimates about the materials conductivity values.
Recent studies have concentrated on this property of the material. There can be a huge
potential of creating a conductive magnesium product that could replace some of the
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existing implants in the market. If there is a way to create a biocompatible solution for a
biodegradable and electrically conductive implant, then a new section of applications
can emerge.
The sample preparation work indicated that the methods for powder forming in the
practical work were very inefficient and time consuming. These methods are not
recommended when testing these irregular types of pieces unless one can find an easy
and safe way to make the material in to a powder or melt it to a solid material piece.
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IAPPENDIX I/IV
pH measurement results
Time (h) 0 3 24 27 48 51 72 75 96 99 168
Sample:
Mg-PLDLA-s 1 7.48 7.51 7.55 7.57 7.67 7.67 7.71 7.70 7.76 7.75 7.86
Mg-PLDLA-s 2 7.48 7.51 7.50 7.54 7.59 7.61 7.62 7.61 7.66 7.66 7.74
Mg-PLDLA-s 3 7.48 7.53 7.60 7.62 7.74 7.75 7.82 7.83 7.87 7.89 7.97
Mg-PLDLA-s 4 7.48 7.49 7.50 7.53 7.60 7.61 7.61 7.63 7.66 7.68 7.75
Mg-PLDLA-s 5 7.48 7.49 7.50 7.51 7.58 7.59 7.62 7.61 7.64 7.66 7.72
Mg-PLDLA-s 6 7.48 7.51 7.55 7.56 7.64 7.65 7.68 7.68 7.70 7.71 7.78
Mg-PLDLA-e 1 7.48 7.52 7.47 7.48 7.52 7.51 7.52 7.54 7.51 7.53 7.52
Mg-PLDLA-e 2 7.48 7.51 7.46 7.49 7.51 7.51 7.53 7.53 7.50 7.52 7.51
Mg-PLDLA-e 3 7.48 7.51 7.47 7.47 7.52 7.51 7.51 7.51 7.50 7.53 7.52
Mg-PLDLA-e 4 7.48 7.50 7.49 7.49 7.54 7.56 7.58 7.56 7.57 7.59 7.60
PLDLA-s 1 7.48 7.50 7.47 7.46 7.50 7.51 7.50 7.49 7.49 7.49 7.49
PLDLA-s 2 7.48 7.50 7.47 7.47 7.50 7.50 7.49 7.51 7.49 7.48 7.51
PLDLA-s 3 7.48 7.53 7.48 7.47 7.51 7.50 7.54 7.49 7.50 7.51 7.48
PLDLA-e 1 7.48 7.51 7.48 7.49 7.49 7.52 7.53 7.49 7.51 7.51 7.49
PLDLA-e 2 7.48 7.51 7.48 7.50 7.49 7.52 7.50 7.52 7.50 7.51 7.48
PLDLA-e 3 7.48 7.52 7.48 7.46 7.49 7.50 7.51 7.49 7.49 7.49 7.49
Mg-1 7.48 7.75 8.12 8.16 8.41 8.40 8.55 8.53 8.65 8.61 8.87
Mg-2 7.48 7.75 8.16 8.21 8.46 8.47 8.64 8.62 8.75 8.72 8.97
Mg-3 7.48 7.71 8.02 8.03 8.17 8.18 8.26 8.25 8.28 8.28 8.35
Mg-4 7.48 7.83 8.27 8.28 8.44 8.46 8.56 8.56 8.61 8.62 8.76
Mg-5 7.48 7.94 8.40 8.41 8.58 8.56 8.70 8.69 8.74 8.75 8.94
Mg-6 7.48 8.05 8.44 8.54 8.81 8.70 8.81 8.81 8.90 8.91 9.25
Mg-Original 1 7.48 7.82 8.27 8.29 8.40 8.40 8.46 8.44 8.48 8.49 8.60
Mg-Original 2 7.48 7.86 8.38 8.40 8.53 8.55 8.62 8.62 8.68 8.69 8.84
Time (h) 0 3 24 27 48 51 120 123 144 144 144.5
Sample:
Mg-Original-
water 1
6.26 9.90 10.66 10.58 10.54 10.50 10.31 10.27 10.15 6.29 9.36
Mg-Original-
water 2
6.28 9.82
II
APPENDIX II/IV
pH measurement results
Time (h) 171 193 216 216 217 218 219 240 243 264 267
Sample:
Mg-PLDLA-s 1 7.86 7.89 7.93 7.50 7.49 7.50 7.54 7.57 7.58 7.67 7.64
Mg-PLDLA-s 2 7.74 7.75 7.78 - - - 7.79 7.79 7.79 7.81 7.80
Mg-PLDLA-s 3 7.98 8.01 8.01 7.50 7.50 7.50 7.54 7.65 7.65 7.77 7.75
Mg-PLDLA-s 4 7.75 7.79 7.82 7.50 7.50 7.49 7.54 7.54 7.53 7.58 7.58
Mg-PLDLA-s 5 7.73 7.75 7.76 - - - 7.75 7.79 7.77 7.77 7.78
Mg-PLDLA-s 6 7.76 7.79 7.82 - - - 7.80 7.82 7.81 7.82 7.82
Mg-PLDLA-e 1 7.53 7.53 7.53 - - - 7.54 7.55 7.54 7.55 7.55
Mg-PLDLA-e 2 7.52 7.53 7.56 - - - 7.52 7.53 7.52 7.53 7.53
Mg-PLDLA-e 3 7.53 7.54 7.55 - - - 7.54 7.53 7.53 7.54 7.53
Mg-PLDLA-e 4 7.58 7.60 7.64 - - - 7.62 7.61 7.61 7.63 7.62
PLDLA-s 1 7.50 7.49 7.48 7.50 7.50 7.48 7.51 7.50 7.49 7.50 7.50
PLDLA-s 2 7.49 7.50 7.50 - - - 7.50 7.48 7.47 7.48 7.47
PLDLA-s 3 7.49 7.49 7.49 7.50 7.50 7.49 7.50 7.50 7.49 7.50 7.49
PLDLA-e 1 7.49 7.50 7.49 7.50 7.49 7.49 7.50 7.49 7.49 7.50 7.49
PLDLA-e 2 7.48 7.50 7.49 - - - 7.49 7.49 7.47 7.48 7.48
PLDLA-e 3 7.48 7.51 7.49 - - - 7.48 7.49 7.48 7.48 7.48
Mg-1 8.85 8.97 8.98 - - - 8.97 9.02 8.99 8.99 9.00
Mg-2 8.94 9.03 9.05 7.49 7.49 7.50 7.51 7.55 7.57 7.62 7.62
Mg-3 8.34 8.38 8.39 - - - 8.36 8.39 8.35 8.38 8.37
Mg-4 8.76 8.79 8.82 7.50 7.50 7.51 7.52 7.52 7.51 7.58 7.58
Mg-5 8.93 8.98 9.00 - - - 8.98 9.02 8.98 9.00 9.00
Mg-6 9.15 9.19 9.22 7.50 7.52 7.51 7.52 7.53 7.54 7.61 7.61
Mg-Original 1 8.60 8.63 8.64 - - - 8.63 8.67 8.64 8.63 8.65
Mg-Original 2 8.83 8.87 8.88 7.49 7.51 7.51 7.51 7.51 7.52 7.55 7.55
Time (h) 145 146 168 171 192 195 216 219 288 291 312
Sample:
Mg-Original-
water 1
9.57 9.43 10.06 9.79 9.65 9.80 9.77 9.80 9.50 9.54 9.50
Mg-Original-
water 2
10.20 10.39 10.60 10.57 10.38 10.37 10.20 10.19 9.78 9.77 9.77
III
APPENDIX III/IV
pH measurement results
Time (h) 336 339 360 363 384 408 432 504 528 528 529
Sample:
Mg-PLDLA-s 1 7.83 7.80 7.81 7.84 7.86 7.90 7.91 7.97 7.99 7.52 7.51
Mg-PLDLA-s 2 7.87 7.85 7.86 7.87 7.88 7.90 7.94 7.94 7.95 - -
Mg-PLDLA-s 3 7.94 7.93 7.96 7.97 7.98 8.00 8.03 8.02 8.02 7.52 7.51
Mg-PLDLA-s 4 7.70 7.68 7.71 7.70 7.73 7.76 7.79 7.84 7.86 7.52 7.49
Mg-PLDLA-s 5 7.84 7.83 7.84 7.86 7.86 7.87 7.90 7.93 7.91 - -
Mg-PLDLA-s 6 7.86 7.85 7.86 7.86 7.88 7.88 7.88 7.92 7.92 - -
Mg-PLDLA-e 1 7.57 7.58 7.56 7.56 7.55 7.58 7.59 7.59 7.61 - -
Mg-PLDLA-e 2 7.55 7.54 7.55 7.56 7.54 7.56 7.56 7.56 7.57 - -
Mg-PLDLA-e 3 7.56 7.55 7.55 7.55 7.56 7.58 7.58 7.58 7.59 - -
Mg-PLDLA-e 4 7.65 7.64 7.64 7.65 7.65 7.66 7.67 7.67 7.68 - -
PLDLA-s 1 7.50 7.49 7.49 7.49 7.49 7.50 7.50 7.50 7.50 - -
PLDLA-s 2 7.48 7.47 7.48 7.49 7.49 7.49 7.49 7.50 7.49 - -
PLDLA-s 3 7.50 7.49 7.49 7.50 7.49 7.50 7.50 7.49 7.50 - -
PLDLA-e 1 7.50 7.49 7.49 7.50 7.48 7.50 7.51 7.50 7.50 - -
PLDLA-e 2 7.50 7.51 7.49 7.48 7.48 7.49 7.49 7.47 7.50 - -
PLDLA-e 3 7.49 7.48 7.49 7.48 7.50 7.50 7.50 7.48 7.53 - -
Mg-1 9.10 9.07 9.11 9.08 9.08 9.11 9.10 9.09 9.08 - -
Mg-2 7.81 7.80 7.88 7.90 7.98 8.08 8.18 8.26 8.30 7.52 7.49
Mg-3 8.39 8.39 8.44 8.43 8.40 8.46 8.47 8.49 8.49 - -
Mg-4 7.71 7.71 7.76 7.78 7.81 7.89 7.94 8.13 8.18 7.52 7.49
Mg-5 9.06 9.06 9.08 9.06 9.07 9.08 9.08 9.08 9.07 - -
Mg-6 7.85 7.86 7.95 7.97 8.06 8.13 8.17 8.26 8.30 7.52 7.49
Mg-Original 1 8.70 8.71 8.74 8.72 8.72 8.75 8.77 8.80 8.78 - -
Mg-Original 2 7.69 7.68 7.71 7.71 7.75 7.82 7.86 8.03 8.08 7.52 7.50
Time (h) 315 336 360 384 456 480 504 528 552 624
Sample:
Mg-Original-
water 1
9.46 9.47 9.41 9.35 9.11 9.24 9.23 9.21 9.14 9.08
Mg-Original-
water 2
9.70 9.65 9.59 9.50 9.26 9.24 9.22 9.21 9.18 9.04
IV
APPENDIX IV/IV
pH measurement results
Time (h) 530 531 552 576 600 672
Sample:
Mg-PLDLA-s 1 7.51 7.51 7.59 7.66 7.67 7.75
Mg-PLDLA-s 2 - - 7.96 7.97 7.94 7.97
Mg-PLDLA-s 3 7.51 7.49 7.54 7.53 7.55 7.59
Mg-PLDLA-s 4 7.50 7.49 7.55 7.60 7.59 7.62
Mg-PLDLA-s 5 - - 7.95 7.94 7.92 7.94
Mg-PLDLA-s 6 - - 7.94 7.92 7.92 7.93
Mg-PLDLA-e 1 - - 7.61 7.60 7.60 7.61
Mg-PLDLA-e 2 - - 7.57 7.58 7.57 7.58
Mg-PLDLA-e 3 - - 7.61 7.61 7.61 7.62
Mg-PLDLA-e 4 - - 7.69 7.69 7.69 7.69
PLDLA-s 1 - - 7.50 7.49 7.52 7.49
PLDLA-s 2 - - 7.51 7.50 7.47 7.48
PLDLA-s 3 - - 7.53 7.49 7.50 7.51
PLDLA-e 1 - - 7.52 7.49 7.50 7.51
PLDLA-e 2 - - 7.49 7.50 7.49 7.48
PLDLA-e 3 - - 7.51 7.51 7.49 7.48
Mg-1 - - 9.08 9.07 9.08 9.07
Mg-2 7.49 7.49 7.53 7.57 7.60 7.73
Mg-3 - - 8.50 8.49 8.53 8.54
Mg-4 7.49 7.50 7.53 7.56 7.61 7.68
Mg-5 - - 9.08 9.07 9.08 9.08
Mg-6 7.49 7.52 7.53 7.57 7.63 7.73
Mg-Original 1 - - 8.80 8.80 8.81 8.84
Mg-Original 2 7.51 7.49 7.53 7.54 7.58 7.65
